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Tobacco and cannabis use often co-occur and are strongly interrelated, with connecting 
mechanisms that likely extend beyond those linking co-use of drugs in general. Among the 
particular mechanisms is the common route of administration. Since both substances are 
usually smoked, using one can serve as cue for the other. On the one hand, this link may 
promote the progression to more frequent use of these substances. On the other hand, it may 
also be problematic in the context of cessation attempts. Evidence suggests that co-users are 
less successful in quitting tobacco and cannabis, respectively, than smokers of only one 
substance. However, current national and international interventions typically focus on one 
substance, and address the other substance either only marginally or not at all. Growing 
evidence suggests a need for dual-interventions for co-users of both substances.  
In line with this, the current thesis aimed at the development and evaluation of 
interventions tailored to co-smokers of tobacco and cannabis. Three research articles (labelled 
Paper 1, 2, and 3) constitute the central part of this thesis. Paper 1 presents the first steps of 
the development process. A preliminary study analysed the demand for and possible designs 
of an intervention for co-smokers through two focus groups and an online survey with current 
and former co-smokers as well as through expert interviews. Because these revealed a 
demand for a combined intervention, we developed an integrative group intervention for 
simultaneous cessation of tobacco and cannabis use. Paper 1 includes a detailed description of 
this dual-intervention and ratings of its acceptability. Both the course participants and the 
course instructors evaluated the program positively and especially appreciated the group 
discussions and modules for developing personal strategies that could be applied during 
simultaneous cessation of tobacco and cannabis.  
Paper 2 evaluates the cessation course regarding feasibility, safety, and initial 
effectiveness, using a within-subjects design with pre-, post-, and 6-month follow-up 
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assessments. Of the 77 participants, 23.4% reported abstinence from cigarettes, cannabis, or 
both at the follow-up. The separate, self-reported abstinence rates for cigarettes and cannabis 
were 10.4% and 19.5%, and cotinine-validated dual-abstinence was achieved by 5.2% at the 
follow-up. Furthermore, the frequencies of tobacco and cannabis use decreased significantly 
over the study period. The treatment retention amounts to 62.3%. Only three participants 
discontinued their participation due to severe problems that emerged during the treatment and 
no hospitalisations as a consequence of course participation were reported. 
Because the preliminary study also indicated only a modest readiness for simultaneous 
cessation, we additionally developed three brief, web-based and fully automated motivational 
interventions that aimed at enhancing co-smokers’ readiness for a simultaneous quit attempt. 
The first intervention combined self-assessments of cigarette and cannabis use with 
personalised, normative feedback, the second one was based on principles of motivational 
interviewing, and the third one merely provided information on tobacco, cannabis, and their 
co-use. Paper 3 evaluates these interventions, using a randomized trial design with pre-, post- 
and 8-week follow-up assessment (N = 325). For the post-intervention assessment, the 
analyses revealed a significant increase in the readiness to quit tobacco and cannabis in the 
total sample, B = 0.33, 95% CI [0.10, 0.56], p = .006. However, this effect was not significant 
for the comparison between baseline and follow-up assessment. Furthermore, no differential 
effects between the interventions were found. In addition, there were no significant 
differential intervention or time effects on the frequency of tobacco or cannabis use. 
The findings indicate that simultaneous treatment of tobacco and cannabis use is 
feasible, at least within the analysed cessation intervention. However, the evaluation of this 
intervention and of the web-based interventions suggest that addressing tobacco and cannabis 
simultaneously is complex and may require more intensive interventions, especially when 
sustained dual-abstinence is the main goal. Future research should take this complexity into 




Cannabiskonsumierende rauchen meist auch Tabak und der Konsum beider Substanzen ist auf 
vielschichtige Weise miteinander verwoben, wobei verbindende Mechanismen vermutlich 
über diejenigen hinausreichen, die Co-Konsum von Substanzen im Generellen erklären. Ein 
wichtiges Verbindungsglied stellt die Konsumform dar: Von der überwiegenden Mehrheit der 
Co-Konsumierende werden beide Substanzen geraucht, wodurch der Konsum der einen 
Substanz als Hinweisreiz für die andere fungieren kann. Daraus kann sich einerseits eine 
Steigerung der Konsumhäufigkeit ergeben; andererseits bereitet dieser Mechanismus aber 
auch häufig im Rahmen von Konsumstoppversuchen Schwierigkeiten. So zeigen Studien, 
dass Co-Konsumierende von Tabak und Cannabis weniger erfolgreich sind beim Ausstieg aus 
dem Tabak- bzw. Cannabiskonsum als Rauchende von nur einer der beiden Substanzen. Trotz 
dieser Befundlage sind nationale und internationale Interventionen für den Ausstieg aus dem 
Tabak- bzw. Cannabiskonsum in der Regel nur auf eine der beiden Substanzen ausgerichtet 
und behandeln die andere entweder gar nicht oder lediglich am Rande. In der Literatur werden 
zunehmend Interventionen gefordert, die auf Co-Rauchende zugeschnitten sind.  
Dementsprechend war das Ziel dieser Dissertation, Interventionen für Co-Rauchende zu 
entwickeln. Drei Artikel (Paper 1, 2 und 3) stellen dabei den zentralen Teil dieser Arbeit dar. 
Paper 1 beinhaltet die ersten Schritte des Entwicklungsprozesses dieser Interventionen. In 
einer Vorstudie wurde der Bedarf an derartigen Interventionen anhand von Interviews mit 
Fachpersonen sowie Fokusgruppendiskussionen und einem Online-Fragebogen mit 
ehemaligen und aktuellen Co-Rauchenden untersucht. Zusätzlich wurden Vorschläge für die 
Ausgestaltung solcher Interventionen gesammelt. Da ein Bedarf festgestellt wurde, wurde im 
Anschluss ein integratives Rauchstopp-Programm zum gleichzeitigen Tabak- und Cannabis-
Ausstieg im Gruppensetting entwickelt. Paper 1 enthält neben der Vorstudie eine detaillierte 
Beschreibung dieser Intervention sowie bereits Befunde zu ihrer Akzeptanz durch die 
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Teilnehmenden und Kursleitenden, welche am Kursende (Teilnehmende) bzw. nachdem alle 
Kurse abgeschlossen waren (Kursleitende) erhoben wurde. Sowohl die Teilnehmenden als 
auch die Kursleitenden bewerteten die Intervention sehr positiv, wobei sie insbesondere die 
Gruppendiskussionen und die Module schätzten, welche zur Entwicklung persönlicher 
Strategien zur Unterstützung beim gleichzeitigen Tabak- und Cannabis-Rauchstopp 
konzeptualisiert worden waren. 
In Paper 2 wird das Rauchstopp-Programm hinsichtlich Machbarkeit, Sicherheit und 
ersten Hinweisen auf Effektivität mit einer Prä-, einer Post- sowie einer Follow-up-Erhebung 
evaluiert. Bei der Follow-up-Messung berichteten 23.4% der 77 Teilnehmenden Abstinenz 
von Zigaretten, Cannabis oder beiden Substanzen. Zigaretten-abstinent waren 10.4% und 
19.5% gaben an, kein Cannabis mehr zu konsumieren. Kombinierte, Cotinin-validierte 
Abstinenz wurde von 5.2% der Teilnehmenden erreicht. Ausserdem nahm die Häufigkeit von 
Tabak- und von Cannabis-Konsum im Laufe der Studienphase ab. Die Haltequote lag bei 
62.3%, wobei nur drei Teilnehmende den Kurs unter anderem wegen schwerer Probleme, die 
sich während des gleichzeitigen Rauchstopp(versuch)s entwickelten, abgebrochen haben. 
Hinweise auf Hospitalisierungen liegen jedoch nicht vor. 
Da die Vorstudie auch nahegelegt hatte, dass die Bereitschaft von Co-Rauchenden, den 
Konsum beider Substanzen gleichzeitig aufzugeben, vermutlich eher mässig ist, wurden 
zusätzlich drei web-basierte, komplett automatisierte Kurzinterventionen entwickelt, die 
darauf abzielten, die Bereitschaft zum gleichzeitigen Tabak- und Cannabis-Rauchstopp zu 
erhöhen. Die erste dieser Interventionen war eine Kombination aus Selbsttest und 
personalisiertem, normativen Feedback, während die zweite Intervention Prinzipien der 
motivierenden Gesprächsführung einsetzte. Die dritte Intervention vermittelte lediglich 
Informationen über den Konsum von Tabak und Cannabis sowie den Co-Konsum beider 
Substanzen. In Paper 3 werden diese Interventionen anhand eines randomisierten 
Studiendesigns mit Prä-, Post- und Follow-up-Messung evaluiert. Insgesamt konnten 325 
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Personen den Interventionen zugewiesen und bei der Datenanalyse berücksichtigt werden. 
Zum Zeitpunkt der Post-Messung direkt nach der Intervention war die Bereitschaft zum 
gleichzeitigen Rauchstopp in der Gesamtstichprobe signifikant höher als vor der Intervention, 
B = 0.33, 95% CI [0.10, 0.56], p = .006. Für den Vergleich der Prä- mit der Follow-up-
Messung wurde aber kein signifikanter Effekt gefunden. Ausserdem ergaben sich keine 
Unterschiede zwischen den verschiedenen Interventionen. 
Gemäss der Befunde dieser Arbeit ist die gleichzeitige Behandlung von Tabak- und 
Cannabis-Konsum zumindest im Rahmen des untersuchten Rauchstopp-Programms machbar. 
Die Evaluation des Rauchstopp-Programms und der web-basierten Interventionen legte aber 
auch nahe, dass aufgrund der Komplexität von gleichzeitigem Intervenieren bei Tabak- und 
Cannabiskonsum möglicherweise intensivere Interventionen erforderlich sind, vor allem 
wenn andauernde Abstinenz von beiden Substanzen als Ziel angestrebt wird. Zukünftige 
Forschung sollte diese Komplexität berücksichtigen und die Wirksamkeit gleichzeitiger 
Behandlung von Tabak- und Cannabis-Konsum mittels randomisiert-kontrollierten Studien 
untersuchen. 
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The use of tobacco and cannabis is common worldwide with important consequences for 
health and quality of life. Tobacco smoking is the major preventable cause of premature death 
and among the three leading risk factors for the global burden of disease (Lim et al., 2012). 
Among the health consequences of tobacco use are respiratory diseases, cancer, and cardio-
vascular diseases (Lim et al., 2012). The global past-month prevalence of tobacco use among 
the population aged 15 and above is 25.0% (UNODC United Nations Office on Drugs and 
Crime, 2012). Cannabis is the most prevalently used illegal drug worldwide with a global 
annual prevalence of 2.6% to 5.0% (UNODC United Nations Office on Drugs and Crime, 
2012). Cannabis use is associated with adverse effects on mental and physical health as well 
as on educational and cognitive outcomes (Caldeira, Grady, Vincent, & Arria, 2012; 
Callaghan, Allebeck, & Sidorchuk, 2013; W. Hall & Degenhardt, 2009). Figures for 
Switzerland present a similar picture. Among the Swiss population aged 15 and above, 18.9% 
smoke tobacco daily and 7.0% are occasional tobacco smokers (Gmel, Kuendig, Notari, 
Gmel, & Flury, 2013). The 12-month prevalence rate of cannabis use is 6.3%, and 3.2% used 
cannabis during the 30 days preceding the survey (Gmel, Kuendig, et al., 2013).  
Tobacco and cannabis use often co-occurs, i.e. tobacco users are more likely to use 
cannabis than tobacco-abstainers (Radtke, Keller, Krebs, & Hornung, 2011; Substance Abuse 
and Mental Health Services Administration, 2013) and vice versa (Richter et al., 2005; 
Rigotti, Lee, & Wechsler, 2000). The use of tobacco and cannabis is linked inextricably 
(Amos, Wiltshire, Bostock, Haw, & McNeill, 2004) and the connecting mechanisms are 
assumed to go beyond those that link co-use of drugs in general (Agrawal, Budney, & 
Lynskey, 2012). This unique relationship is relevant in the context of initiation and 
progression of tobacco and cannabis use, and is particularly pronounced in the context of 
cessation (Amos et al., 2004). 
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The body of literature on co-use of tobacco and cannabis is growing. In 2012, three 
reviews on co-occurring tobacco and cannabis use were published (Agrawal et al., 2012; 
Peters, Budney, & Carroll, 2012; Ramo, Liu, & Prochaska, 2012). Up to now, most 
publications are epidemiological studies and focus on the role of tobacco and cannabis use in 
the initiation and progression of either substance use. Fewer studies examined the relationship 
of tobacco and cannabis use in the context of cessation (see section 2.1.4). Some of them are 
observational studies analysing quit attempts and quit success of co-smokers compared to 
smokers of only one substance. Other studies examined the effectiveness of treatment that 
addresses only tobacco or cannabis use for co-smokers compared to single-smokers. 
However, there is a considerable lack of research on interventions for co-smokers. So far, 
only one small pilot study of an intervention tailored for co-smokers has been published (Hill 
et al., 2013). In addition, a few studies have examined brief interventions for universal drug 
prevention or early intervention which targeted tobacco and cannabis besides other drug use 
and health behaviour (McCambridge, Hunt, Jenkins, & Strang, 2011; McCambridge, Slym, & 
Strang, 2008; McCambridge & Strang, 2004, 2005). Promising results originate also from 
tobacco cessation interventions that are integrated into treatment of other substance use. 
In their review, Ramo and colleagues concluded that “there is a great need to develop 
prevention and intervention programs that address the co-use of [tobacco] and [marijuana]” 
(Ramo et al., 2012, p. 114) and the authors of the other reviews reached similar conclusions 
(Agrawal et al., 2012; Peters et al., 2012). In line with this, the aim of the current thesis was to 
extend research on co-use of tobacco and cannabis by developing and evaluating interventions 
that are tailored for co-smokers of both substances.  
First, a preliminary study was conducted to analyse the demand of an intervention for 
co-smokers of tobacco and cannabis and to collect suggestions for its design. The interviewed 
experts and co-smokers confirmed a demand for tailored interventions, but the readiness of 
co-smokers to stop tobacco and cannabis use simultaneously was expected to be modest. 
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Therefore, three brief, web-based motivational interventions were developed that aimed at 
enhancing co-smokers’ readiness for a simultaneous quit attempt. Furthermore, an integrative 
group cessation course for co-smokers of tobacco and cannabis was developed. Three 
research articles (labelled Paper 1, 2, and 3) constitute the central part of this thesis. Paper 1 
describes the results of the preliminary study, the developed smoking cessation intervention, 
and the results of its acceptability study. Paper 2 analyses the cessation course regarding its 
feasibility, safety, and initial effectiveness. Finally, Paper 3 evaluates the web-based 
motivational interventions. 
In the following, the chapter Background provides an overview of the existing evidence 
on co-use of tobacco and cannabis in general and on interventions for tobacco and cannabis 
use in particular. Subsequently, the chapter The Current Thesis includes the research 
questions and summarizes the three papers. The following General Discussion illuminates the 
main findings according to the research questions. It also considers methodological aspects of 
the studies that form this thesis. Furthermore, an outlook on future research and implications 






2.1. The Relationship between Tobacco and Cannabis Use 
2.1.1. Forms of Co-Occurring Tobacco and Cannabis Use 
In general, multiple substance use can be subdivided in two forms, depending on the 
time-frame in which the substances are consumed (Earleywine & Newcomb, 1997). 
While simultaneous use refers to the use of two or more substances on a single occasion 
or sequentially close in time, concurrent use defines the use of two or more substances 
during lifespan or within a certain time period, e.g. within one year. Simultaneous use is 
therefore a sub-form of concurrent use (Martin, 2008).  
In the case of tobacco and cannabis, simultaneous use can occur in two ways. 
First, both substances can be co-administered by smoking cannabis mixed with tobacco, 
i.e. mulling (cannabis-joints mixed with tobacco) or smoking blunts (cannabis in a cigar 
shell) (Sifaneck, Johnson, & Dunlap, 2005). Cannabis is often co-administered with 
tobacco to ensure that it burns smoothly (Patton, Coffey, Carlin, Sawyer, & Lynskey, 
2005). Second, both substances can be used directly after each other which is referred to 
as chasing cannabis with tobacco cigarettes or cigarillos (Sifaneck et al., 2005). In the 
empirical part of this thesis, the terms co-smoking and co-smokers refer to those who 
concurrently smoke both a tobacco product (cigarettes, tobacco pipes, cigars etc.) and a 
cannabis product (cannabis joint mixed with tobacco or pure cannabis joint).  
2.1.2. Prevalence, Correlates, and Consequences of Co-Use 
The co-use of tobacco and cannabis is one of the most common combinations of poly-
drug-use in adolescents and young adults (Ramo et al., 2012). For Switzerland, no data 
are available on how many individuals show any concurrent use of tobacco and 
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cannabis. Instead, population surveys differentiate according to different variables such 
as use intensity and age group. According to the Swiss Addiction Monitoring, in 2012  
 18.9% of the Swiss population aged 15 and above were daily tobacco smokers, 7.0% 
smoked occasionally, 23.0% were former smokers, and 51.0% had never smoked 
tobacco (Gmel, Kuendig, et al., 2013). Regarding cannabis use, the lifetime, 12-month, 
and 30-day prevalence was 29.6%, 6.3%, and 3.2%. In the age-group of 15 to 19 years, 
2.4% of the non-smokers reported frequent, i.e. at least weekly, cannabis use whereas 
the remaining 97.6% used cannabis either less frequently or not at all. In contrast, the 
prevalence of frequent cannabis use was higher among the occasional (12.0%) and the 
daily tobacco smokers (7.2%). Reciprocally, among those who did not report any 
cannabis use during the past 30 days, 18.3% were daily tobacco smokers. Among the 
occasional cannabis users the prevalence of daily tobacco smokers was 66.4% and 
among the frequent cannabis users it was 34.4%. How many of the remaining 33.6% 
and 65.6%, respectively, were occasional tobacco smokers and how many were non-
smokers is not clear.  
Concerning co-administration of tobacco and cannabis in Switzerland, a recent 
study among young men (Cohort Study on Substance Use Risk Factors, C-SURF) 
revealed, that smoking cannabis in joints is by far the most common way. Of the 5’990 
participants, 30.7% had used cannabis during the 12 months preceding the survey 
(Baggio et al., 2013). Of these, 97.3% reported using joints with tobacco, either solely 
or together with other routes of administration. The second frequently applied routes 
were joints without tobacco (38.2%) and cannabis mixed with food (37.2%), followed 
by waterpipes with tobacco (29.3%) and without tobacco (24.0%). Furthermore, another 
study among Swiss cannabis users aged around 15 years found that even among 
cigarette abstainers the majority administers cannabis mixed with tobacco (Bélanger, 




While tobacco and cannabis use are clearly associated with each other, the factors 
which predict co-use are less clear (Ramo et al., 2012). In their review, Ramo and 
colleagues (2012) identified only few consistent correlates and consequences of co-use, 
namely African-American ethnicity, some mental and physical health characteristics 
(e.g. high-intensity pleasure temperament), and school characteristics (e.g. good grades) 
(Ramo et al., 2012). Furthermore, increased age was correlated with co-use. Concerning 
sex differences in the co-use of tobacco and cannabis, findings are not consistent (Ramo 
et al., 2012).  
Findings regarding the association between co-use of tobacco and cannabis with 
severity of use are also inconsistent. However, co-users seem to have a greater 
likelihood of cannabis use disorders compared with cannabis-only users, but co-use 
does not seem to be consistently correlated with a greater likelihood of tobacco use 
disorders compared to tobacco-only users (Peters et al., 2012). Contrary to this, 
Agrawal and colleagues (2012) found elevated rates of nicotine dependence among 
those who had at least once used cannabis and higher rates of cannabis use disorders 
among those who had at least once smoked cigarettes. A study that analysed the way of 
cannabis administration revealed that using marijuana with tobacco (smoking blunts and 
chasing) was positively associated with the number of cannabis dependence symptoms 
(Ream, Benoit, Johnson, & Dunlap, 2008). One further study which analysed 
differential use frequency found that co-smokers smoked less tobacco compared to 
tobacco-only smokers but were using more cannabis than cannabis-only users (Bonn-
Miller, Zvolensky, & Johnson, 2010).  
As a consequence of co-occurring tobacco and cannabis use, several studies have 
fournd the exacerbation of mental health symptoms, such as depressive symptoms (Lee 
Ridner, Staten, & Danner, 2005) or a depression diagnosis (Boys et al., 2003). 
Furthermore, the majority of the studies that analysed risk behaviour (i.e. drug driving, 
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unsafe sex, high school drop-out) and neurocognitive impairment (i.e. memory, 
processing speed, nicotine reward/reinforcement) detected positive associations with co-
use. Physical health effects of co-smoking are hardly known (Ramo et al., 2012). 
However, two studies indicate that co-use is associated with respiratory problems in 
young adulthood (Taylor et al., 2002; Taylor, Poulton, Moffitt, Ramankutty, & Sears, 
2000), but it is unknown whether co-use results in chronic physical health problems 
(Ramo et al., 2012). Furthermore, it is unclear whether some adverse effects of tobacco 
use and cannabis use, respectively, are compensated and others are added or multiplied 
when tobacco and cannabis are used concurrently.  
2.1.3. Mechanisms Underlying Co-Use of Tobacco and Cannabis  
In their review, Ramo et al. (2012, p. 112) summarize: “Clearly, the use of one 
substance increases the likelihood of concurrent or future use of the other substance“. 
However, the linking mechanisms are less clear, but they are assumed to go beyond the 
mechanisms underlying co-use of substances in general (Agrawal & Lynskey, 2009a). 
In the following, several mechanisms that link tobacco and cannabis use at multiple 
stages in their progression of use will be specified, whereas the next chapter will focus 
on the cessation of use among co-smokers. The relative importance of the presented 
mechanisms that contribute to co-use of tobacco and cannabis may vary across 
development (Agrawal, Silberg, Lynskey, Maes, & Eaves, 2010) and stages of use 
(Agrawal et al., 2012). 
The gateway hypothesis (D. B. Kandel, 2002; D. Kandel, 1975) suggests that the 
sequence of drug use initiation is uniform and developmentally deterministic 
(Vanyukov et al., 2012). It assumes that the use of licit substances, i.e. tobacco and 
alcohol, is a gateway to cannabis use which then, in turn, “sets an individual on a 




hypothesis, several studies found an increased likelihood of starting cannabis use among 
tobacco users compared to non-tobacco users (Agrawal & Lynskey, 2009b; Korhonen et 
al., 2010). Using the baseline and 18-month follow-up data of the C-SURF study, we 
also analysed this gateway sequence and found that cigarette use was among the 
strongest predictors of late onset of cannabis use among young men (Haug, López 
Núñez, Becker, Gmel, & Schaub, submitted)1. Furthermore, tobacco use also seems to 
predict progression of cannabis use to problematic cannabis use or dependence (Swift, 
Coffey, Carlin, Degenhardt, & Patton, 2008). However, several studies found also the 
reverse sequence, i.e. cannabis was used before tobacco and predicted the onset of 
tobacco use (Ford, Vu, & Anthony, 2002; Patton et al., 2005; Tullis, DuPont, Frost-
Pineda, & Gold, 2003). This sequence is referred to as reverse gateway effect (Patton et 
al., 2005). Moreover, cannabis use can also predict progression to higher involved 
stages of tobacco use, such as daily cigarette use and nicotine dependence (Agrawal, 
Madden, Bucholz, Heath, & Lynskey, 2008; Patton et al., 2005; Timberlake et al., 
2007). The results of a second analysis that we conducted with the C-SURF data are in 
line with these findings. Our analyses accounted for a comprehensive set of variables 
including demographic background, religion and religiosity, health and health 
behaviour, social context, licit substance use and illicit substance use other than 
cannabis, personality, and military training status. However, cannabis use was still one 
of the strongest predictors of onset of daily cigarette smoking (Becker, Schaub, Gmel, 
& Haug, in preparation)2. The Swiss Tobacco Monitoring study assessed the sequence 
of tobacco and cannabis onset among adolescents with co-occurring tobacco and 
cannabis use with retrospective self-reports. The major part (58%) had smoked tobacco 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
1 The manuscript of this study has been submitted to a journal and can be requested 
from the author of this thesis. 
2	  The manuscript of this study is available as a draft and can be requested from the 
author of this thesis. 
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first, 38% had used cannabis first, and 2% had simultaneously started with both 
substances, with a higher percentage of women reporting tobacco use first (69%) 
compared to men (51%) (Radtke, Keller, Krebs, & Hornung, 2008).  
A competing concept is the common liability model. This assumes that not the use 
of a gateway drug puts an individual at risk for also using illicit substances such as 
cannabis but a common liability to using both licit and illicit drugs. This liability may 
include a genetic and individual vulnerability, such as proneness to deviancy and 
familial liability to addiction (van Leeuwen et al., 2011). The existing evidence 
concerning genetic factors suggests that there is a specific genetic overlap between 
liability to tobacco and cannabis use that extends beyond heritability of a general 
liability to externalizing problems and of a general propensity to drug use and misuse 
(Agrawal et al., 2012). However, environmental and not genetic factors seem to account 
for the largest variance in co-use of tobacco and cannabis (Ramo et al., 2012). Peer 
influences appear to be one factor that influences individual vulnerability. Analysing the 
origins of the correlation between tobacco, alcohol, and cannabis use among 
adolescents, an Australian study found an individual’s vulnerability to substance use as 
an explaining factor (Lynskey, Fergusson, & Horwood, 1998). The vulnerability, in 
turn, was predicted by the extent to which the individual was affiliated with delinquent 
and substance using peers. 
Another explanation for the normative sequence of drug use initiation is 
differential availability of tobacco and cannabis. Economic studies illustrate how 
availability may affect co-use. These studies indicate that tobacco and cannabis serve as 
complements, i.e. increasing cigarette prices result in decreasing cigarette and also 
decreasing cannabis use (Chaloupka et al., 1999; Farrelly, Bray, Zarkin, & Wendling, 
2001), and vice versa (Cameron & Williams, 2001). Findings of the reversed sequence 




only factor that contributes to the traditional sequence.  
The way of administration is probably among the most important connecting 
mechanisms of tobacco and cannabis use. In the qualitative study of Amos and 
colleagues (2004), many participants made the experience that smoking joints, i.e. co-
administration, served as gateway to smoking cigarettes. On the one hand, a quantitative 
study found that many of the participating college students learned inhalation through 
smoking marijuana (i.e. shared route of administration) and subsequently smoked both 
marijuana and tobacco (Tullis et al., 2003). The relevance of the way of administration 
is also underlined by a study of Agrawal and Lynskey (2009b) in which smoking 
tobacco was significantly associated with cannabis use and dependence whereas use of 
smokeless tobacco was not. 
Due to the shared route of administration, tobacco smoking and cannabis smoking 
may serve as behavioural cue for each other and therefore reinforce each other (Agrawal 
& Lynskey, 2009a). Moreover, cross-drug reinforcement of tobacco and cannabis use 
happens also on a pharmacological level. Tobacco and cannabis affect the same neural 
pathways, with some systems being mutually enhanced by the two substances and 
others having contrasting effects (Viveros, Marco, & File, 2006) and nicotine may 
prolong and enhance the subjective effects of cannabis (Penetar et al., 2005; Tullis et 
al., 2003).  
2.1.4. Cessation of Tobacco and Cannabis Use Among Co-Smokers 
The following part summarizes the evidence on quit attempts and quit success among 
co-smokers. First, it presents findings from observational studies and findings from 
clinical interventions that targeted only one substance but measured also the use of the 




While co-use of tobacco and cannabis seems to be associated with poorer 
cannabis cessation outcomes compared to cannabis-only use, there appears to be no 
consistent association with poorer tobacco cessation outcomes compared to tobacco-
only users (Peters et al., 2012). Regarding tobacco cessation during observational 
studies, one study on 2033 adolescents found a decreased likelihood of successfully 
stopping tobacco smoking among those with a history of marijuana use (Abrantes et al., 
2009). Similar results were found in a study that reassessed 431 tobacco smoking adults 
after 13 years (Ford et al., 2002). Those who had used marijuana during the 30 days 
preceding the baseline measurement made fewer attempts to quit tobacco and were 
more likely to still use tobacco at the follow-up, with daily marijuana use being even 
stronger associated with continued tobacco smoking. Contrary to these findings, a 10-
year cohort study in Australia which followed 1943 adolescents initially aged 14-15 
years into young adulthood found little evidence for an impact of cannabis use on the 
likelihood of smoking cessation (Patton et al., 2005). Longitudinal studies comparing 
cannabis quit attempts and quit success between cannabis-only users and co-users are 
lacking. 
The evidence regarding differential success of co-smokers and smokers of only 
one substance in single-interventions is scarce because many single-treatment studies 
did not access the use of the not-treated substance or did at least not analyse its 
influence on treatment outcome. Moreover, use of other substances than tobacco is 
often an exclusion criterion in smoking cessation trials, leading to limited evidence on 
treatment success among co-smokers. However, most of the studies that took into 
account both substances have shown that co-smokers were less likely successful in 
tobacco-only interventions (Gourlay, Forbes, Marriner, Pethica, & McNeil, 1994; 
Stapleton, Keaney, & Sutherland, 2009) and cannabis-only interventions (de Dios, 




Nevertheless, several studies of single-interventions for tobacco cessation did not find 
such differences (Humfleet, Muñoz, Sees, Reus, & Hall, 1999; Metrik, Spillane, 
Leventhal, & Kahler, 2011). Methodological differences limit the comparability of the 
studies, e.g. not all studies accounted for baseline differences between the groups.  
Several reasons might explain the lower quit rates of co-smokers. First, 
motivational factors seem to differ between co-smokers and smokers of only one 
substance. Co-smokers seem to be less likely to plan tobacco cessation compared to 
tobacco-only smokers (Ramo, Delucchi, Hall, Liu, & Prochaska, 2013). However, some 
findings indicate that co-smokers’ motivation to quit cannabis use is even lower since 
cannabis appears to have a more positive functional value and is viewed as less harmful 
compared to cigarettes (Amos et al., 2004; Highet, 2004; J. P. Lee, Battle, Lipton, & 
Soller, 2010; Sifaneck et al., 2005). 
A further potential explanation for the decreased likelihood among co-smokers to 
successfully quit tobacco and cannabis, respectively, is the already mentioned cross-
drug reinforcement via the way of administration and common pharmacological 
processes (Agrawal et al., 2012). This is especially relevant when co-smokers try to quit 
only one substance, since each smoked cigarette or joint may cue the use of the 
substance intended to quit. Cross-drug reinforcement may also explain the substitution 
phenomenon which individuals often experience when trying to quit one substance, i.e. 
the increased use of the substance not intended to quit (Akré, Michaud, Berchtold, & 
Suris, 2010; Amos et al., 2004; Copersino et al., 2006; Haney et al., 2013).  
One important barrier to single-cessation of tobacco or cannabis and in particular 
to simultaneous cessation is the experience of withdrawal. While tobacco withdrawal is 
well documented (Hughes, 2007), the existence of cannabis withdrawal has long been 
debated (Smith, 2002) and cannabis withdrawal has only been included in the new 
DSM-V (American Psychiatric Association, 2013). Growing evidence indicates that 
BACKGROUND 
24 
cannabis withdrawal is common and clinically significant (Agrawal, Pergadia, & 
Lynskey, 2008; Budney & Hughes, 2006; Hesse & Thylstrup, 2013), and little doubt 
remains in the reliability and validity of the cannabis withdrawal symptom (Agrawal et 
al., 2012). On the one hand, tobacco and cannabis withdrawal share many symptoms, 
such as restlessness, difficulties with concentration, sleep difficulties, increased anger, 
and increased aggression (Budney, Vandrey, Hughes, Thostenson, & Bursac, 2008; 
Vandrey, Budney, Hughes, & Liguori, 2008). On the other hand, both have also unique 
symptoms: Irritability and decreased appetite are associated stronger with cannabis 
withdrawal, while increased appetite and craving are more typical for tobacco 
withdrawal (Budney et al., 2008). One study indicates that withdrawal during cessation 
of tobacco alone and cannabis alone is of a similar magnitude but stronger during 
simultaneous cessation (Vandrey et al., 2008). However, substantial individual 
differences were noted and the differences regarding the severity lasted only for two 
days. 
2.2. Interventions for Tobacco and Cannabis Users 
This chapter summarizes the existing evidence on interventions for tobacco and 
cannabis users. First, an overview presents the most established approaches for single-
treatment of tobacco and cannabis use. Subsequently, evidence regarding their efficacy 
in the treatment of tobacco and cannabis use, respectively, is summarized. Next, 
tobacco cessation interventions that are integrated in interventions for other substance 
use are reviewed. Compared to integrated tobacco cessation interventions, evidence on 
the efficacy of combined treatment of cannabis and other problematic substance use is 
lacking. Subsequently, universal interventions for substance use which also target 
tobacco and cannabis use are presented. Finally, the only published evaluation of an 




the interventions evaluated in Paper 3 of this thesis are web-based, the sections also 
touch the effectiveness of web-based interventions in the particular behaviour if 
appropriate evidence is available. 
2.2.1. Overview of Psychotherapeutic Treatment Approaches 
In the following, the most established approaches of face-to-face and web-based 
interventions for adult smokers of tobacco and/or cannabis are briefly summarised.  
An established counselling technique for building motivation to change substance 
use behaviour is motivational interviewing (MI). MI is defined as “a client-centered, 
directive method for enhancing intrinsic motivation to change by exploring and 
resolving ambivalence” (Miller & Rollnick, 2002, p. 25). A particular spirit, based on 
the three elements collaboration between the therapist and the client, evocation of 
intrinsic motivation for change, and emphasizing the autonomy of the client, 
characterizes MI. Fundamental techniques are open-ended questions, affirmations, 
reflective listening, and periodical summaries. Methods such as using an importance 
ruler and exploring decisional balance aim to elicit change talk, i.e. statements by the 
client that express consideration of, or motivation for change (Miller & Rollnick, 2002).  
Personalised, normative feedback interventions are based on the social norms 
approach (Perkins, 2003). They typically include self-assessment sections and feedback 
sections in which the participant’s behaviour is compared to a reference sample. The 
overestimation of substance use of others is common and its degree is positively 
associated with one’s own use (Bertholet, Faouzi, Studer, Daeppen, & Gmel, 2013). 
Social norm interventions built upon this association and aim to correct the client’s 
erroneous perceptions.  
Based on social learning theory, cognitive behavioural therapy (CBT) in 
substance abuse treatment assumes that drug dependence is at least in part an acquired 
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behaviour pattern (Stephens, Roffman, Copeland, & Swift, 2006). CBT is often 
combined with motivational enhancement interventions such as MI. A particular focus 
is put on relapse prevention (RP) (Marlatt & Gordon, 1985). RP aims at the 
identification and prevention of high-risk situations such as craving symptoms. Self-
monitoring assignments are a common technique to identify personal high-risk 
situations and their antecedents. The development of cognitive and behavioural coping 
skills such as withdrawal management, relaxation techniques, and drug refusal skills is 
at the core of RP (Roffman & Stephens, 2005; Shiffman, Kassel, Gwaltney, & 
McChargue, 2005).  
Contingency management (CM) interventions are used as adjuncts or as stand-
alone treatment. Based on operant conditioning, they systematically provide incentives 
and disincentives to promote changes in substance use, therapy attendance, or 
medication compliance (Higgins, Silverman, & Heil, 2008).  
Originally applied to treatment of alcohol use, the Community Reinforcement 
Approach (CRA) was later widened to other substances. It aims to replace 
environmental contingencies that have reinforced alcohol or drug use with prosocial 
activities and behaviours (Godley et al., 2001). 
Web-based interventions for tobacco use are increasingly popular. Delivering 
interventions through the Internet has several advantages over face-to-face treatment. 
On the side of the client, the threshold to use web-based interventions is low given that 
their access is usually possible anytime and anywhere, that they are usually free of cost 
and can be accessed anonymously, and that their use is less stigmatized (Copeland & 
Martin, 2004). On the side of the public health system, costs are comparatively low, 
especially if interventions are fully automated. These kinds of interventions can be 
individually tailored by adaptive filtering and feedback but do not require treatment 




the presentation of personalised, normative feedback (e.g. Doumas & Hannah, 2008; 
Haug, Meyer, & John, 2011). Furthermore, some web-based interventions are based on 
MI that is usually implemented as a chat-intervention rather than being delivered fully 
automated (e.g. Jonas, Tossmann, Tensil, Leuschner, & Strüber, 2012; Woodruff, 
Conway, Edwards, Elliott, & Crittenden, 2007). 
2.2.2. Interventions for Tobacco Use 
According to an overview of recent Cochrane reviews on single-interventions for 
tobacco addiction, behavioural support in combination with medication such as nicotine 
replacement therapy (NRT), bupropion, or varenicline is the most effective treatment 
approach (Hartmann-Boyce, Stead, Cahill, & Lancaster, 2013). Moreover, the reviews 
indicate that the efficacy of behavioural support exceeds the efficacy of 
pharmacotherapy. Both, group therapy compared with self-help only and individual 
counselling compared with minimal contact are effective (Hartmann-Boyce et al., 
2013). However, differential effectiveness of group versus individual therapy has not 
been detected so far (Stead & Lancaster, 2009). Furthermore, mobile phone technology 
and training of health professionals in smoking cessation are effective in promoting 
tobacco cessation. With regard to motivational interventions, MI is superior to brief 
advice/usual care whereas stage based counselling and standard advice seem to be 
equally effective (Hartmann-Boyce et al., 2013).  
A systematic review categorizes the evidence supporting the use of web-based 
smoking cessation interventions as insufficient to moderate in adults and insufficient in 
college students and adolescents (Hutton et al., 2011). The efficacy of web-based 
smoking cessation in adults seems to be modest and more personalized and intensive 
web-based interventions may be more effective regarding smoking cessation (Civljak, 
Stead, Hartmann-Boyce, Sheikh, & Car, 2013; Hutton et al., 2011). 
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2.2.3. Interventions for Cannabis Abuse and Dependence 
For the treatment of cannabis use, a number of psychotherapeutic interventions such as 
CBT, motivational enhancement therapy, and social support interventions seem to be 
effective (Benyamina, Lecacheux, Blecha, Reynaud, & Lukasiewcz, 2008; Denis, 
Lavie, Fatseas, & Auriacombe, 2006; Nordstrom & Levin, 2007). No form of 
psychotherapy has shown superior effectiveness, with the exception of voucher-based 
interventions when used in combination with other effective psychotherapeutic 
interventions (Denis et al., 2006; Nordstrom & Levin, 2007). Furthermore, treatment 
length seems to have no association with treatment success (Nordstrom & Levin, 2007). 
For example, one randomized controlled trial compared 1) 4-session of relapse 
prevention in combinations with social support, 2) two sessions of individualized 
assessment and intervention including motivational enhancement and cognitive-
behavioural techniques, and 3) a delayed treatment control group (Stephens, Roffman, 
& Curtin, 2000). Compared to the control group, participants of both intervention 
groups significantly reduced their cannabis use frequency. However, the two 
intervention groups did not differ regarding their effectiveness. Furthermore, both 
individual and group treatment of cannabis use has been found to be effective (Stephens 
et al., 2006). Contrary to the treatment of tobacco use, for cannabis use treatment no 
medication has been shown consistent effectiveness so far (Budney, Roffman, Stephens, 
& Walker, 2007). Moreover, while the usual goal of interventions for tobacco use is 
abstinence, interventions for cannabis abuse and/or dependence often aim at the 
reduction of use frequency. However, abstinence goals seem to predict better outcomes 
(Budney et al., 2007). Abstinence rates following cannabis treatment are relatively 
small (Denis et al., 2006). For continued abstinence, they vary between 15 and 37% 
(Haney et al., 2013). With regard to reduction, treatment among adolescents results in 




(Bender, Tripodi, Sarteschi, & Vaughn, 2011).  
Taking into account the increasing demand for cannabis treatment (European 
Monitoring Centre for Drugs and Drug Addiction, 2012), it is important to investigate 
web-based interventions for cannabis users. The first meta-analysis on Internet and 
computer based treatment of cannabis use has been published recently (Tait, 
Spijkerman, & Riper, 2013). The analysis of the data which were extracted from 10 
studies revealed a small but significant pooled effect size at post-treatment. Hence, 
Internet and computer based interventions appear to be effective in reducing cannabis 
use at least in short-term. 
2.2.4. Integrated Tobacco Cessation Interventions 
For a long time, tobacco treatment was not included in substance abuse treatment 
settings. Tobacco treatment is by far not offered in every addiction treatment program, 
although individuals in substance abuse treatment have high tobacco use prevalence 
rates and a large proportion is interested in smoking cessation (S. M. Hall & Prochaska, 
2009; J. J. Prochaska, Delucchi, & Hall, 2004). Fuller and colleagues (2007) mention 
several barriers to the integration of tobacco treatment in substance abuse treatment. 
Among them are the high cigarette smoking prevalence among treatment staff, a culture 
amenable to smoking, and attitudes of staff. One of these attitudes is the view that 
tobacco cessation has a lower priority because of its few immediate consequences in 
comparison to alcohol and non-nicotinic drugs. Prochaska and colleagues (2004) 
discuss a further important barrier is the concern of many clinicians that tobacco 
cessation would have detrimental effects on the outcomes of the primary treated 
substance (J. J. Prochaska et al., 2004).  
Several reviews (Baca & Yahne, 2009; J. J. Prochaska et al., 2004; J. J. 
Prochaska, 2010; Richter & Arnsten, 2006) summarize the findings of smoking 
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cessation interventions during substance abuse treatment. Many of them are integrated 
tobacco cessation interventions integrated in treatment of alcohol dependence. 
According to the pooled analysis of Prochaska and colleagues (2004), intervention 
effects for smoking cessation were significant at short-term but not at long-term. 
However, contrary to the common concern, they found that smoking cessation 
interventions during addiction treatment seem to enhance rather than impair the 
outcome success of the substance abuse treatment. Baca and Yahne (2009) reported the 
same finding. Furthermore, more recent studies on the integration of tobacco cessation 
into treatment of alcohol dependence (Mueller, Petitjean, & Wiesbeck, 2012; Nieva, 
Ortega, Mondon, Ballbè, & Gual, 2010) and opioid dependence (Dunn, Sigmon, 
Reimann, Heil, & Higgins, 2009) revealed similar results. 
2.2.5. Interventions Targeting at Multiple Behaviours Including Tobacco and 
Cannabis Use 
In the following, several multiple behaviour interventions that target tobacco and 
cannabis use besides other health behaviours are presented. However, none of these 
studies explicitly took into account co-occurring tobacco and cannabis use. 
McCambridge and colleagues (McCambridge et al., 2011, 2008; McCambridge & 
Strang, 2003, 2004, 2005) evaluated several brief interventions targeting tobacco and 
cannabis use among other substances. One study analysed a 1-hour single-session 
intervention that was adapted from MI and structured by a series of topics 
(McCambridge & Strang, 2004). The intervention targeted at young people between 16 
and 20 years and was conducted in their school classes. Compared to the control group 
(‘education-as-usual’), the participants of the intervention group significantly reduced 
their use of cigarettes, alcohol, and cannabis at the 3-month follow-up. Although these 




time were detected in the intervention group: those who had smoked cigarettes and 
those who had used cannabis at baseline had a decreased frequency of cigarette and 
cannabis, respectively (McCambridge & Strang, 2005). In two further studies, 
McCambridge and colleagues compared the effectiveness of a single-session of 
individual MI with individual psychoeducation (McCambridge et al., 2008) and with 
classroom advice (McCambridge et al., 2011). In both studies, no differences in the 
effectiveness of the interventions were found, but all participants had significantly 
reduced their use of tobacco, cannabis, and alcohol over time.  
Werch and colleagues (Werch, Moore, DiClemente, Bledsoe, & Jobli, 2005; 
Werch et al., 2011) evaluated two brief integrative multiple behaviour interventions 
among high school students. The first intervention (“Project SPORT”) consisted of a 
health behaviour screen, a one-on-one consultation lasting around 12 minutes, a take 
home fitness prescription and a reinforcing follow-up flyer. The minimal intervention 
control comprised a wellness brochure provided in school and a pamphlet about teen 
health and fitness mailed to the home. A total of 604 participants were randomized to 
one of the conditions. The results revealed significant positive effects for cigarette and 
marijuana use both at the 3-month and the 12-month follow-up (Werch et al., 2005). 
The intervention (“Project Active”) was evaluated with 479 students and consisted 
in a one-on-one consultation lasting on average 30 minutes. This included assessment 
and personalized feedback on fitness including tobacco, alcohol and illegal drug use. 
Participants of the control condition received a booklet about wellness in adolescents. 
While participants of the intervention significantly reduced their alcohol use frequency 
and quantity and improved their fruit and vegetable intake as well as their stress 
management, no significant reduction in tobacco or marijuana use was detected at the 3-
month follow-up. Marijuana use increased in both groups, but this difference was not 
significant. The authors explained the lack of significant effects for cigarette use with 
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the small sample of cigarette users (n = 34). As possible explanation for the results 
regarding marijuana use, they mentioned differential attrition among marijuana users 
and that the intervention did not address marijuana use specifically but illegal drug use 
more general (Werch et al., 2011).  
In general, web-based interventions targeting several health behaviours 
simultaneously have shown promising effects (Krebs, Prochaska, & Rossi, 2010). 
However, to the best of the author’s knowledge multiple behaviour interventions that 
also target tobacco use in a web-based setting have not yet been evaluated. 
2.2.6. Treatment Tailored to Co-users of Tobacco and Cannabis  
So far, only one intervention that is tailored explicitly to co-smokers of tobacco and 
cannabis has been published (Hill et al., 2013). So far, it was only evaluated in a small 
pilot study. It is important to note that this intervention was not yet published when we 
conducted the preliminary study, conceptualized and implemented the interventions that 
are evaluated in this thesis. The intervention consisted of individual CBT sessions that 
were delivered during 10 weeks in combination with transdermal patch NRT. A target 
quit date for both substances was set after the first CBT session. Of the 12 participants 
who started the treatment, seven completed the treatment and were analysed regarding 
changes in use frequency of tobacco and cannabis. The participants significantly 
reduced their tobacco cigarette use from 12.6 cigarettes per day at baseline to 2.1 at the 
end of treatment. The change in cannabis use from 10.0 to 8.0 inhalations per day was 
not significant. No follow-up assessment was reported.  
Up to now, neither motivational nor behavioural web-based interventions that 
target co-smokers have been published so far.  
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3. THE PRESENT THESIS 
3.1. Overview and Research Questions 
In this chapter, the three manuscripts that constitute the central part of this thesis are briefly 
summarized. The first step in the development of the interventions was a preliminary study 
including a demand analysis. Because this confirmed great interest in a cessation intervention 
for co-smokers, we proceeded with designing and implementing a group cessation program 
according to suggestions collected in the preliminary study. Paper 1 reports the results of the 
preliminary study and also gives a detailed description of the intervention design. In addition, 
Paper 1 already includes ratings of intervention acceptability that were assessed among 
participants after the last course session and among course instructors after all courses had 
been conducted. Paper 2 evaluates the group cessation intervention in terms of feasibility and 
initial effectiveness, using a within-participants design with pre-, post-, and 6-month follow-
up assessments. The demand for the intervention (Paper 1) was accompanied by only modest 
readiness for simultaneous cessation among co-smokers, which led to the development of 
three brief web-based motivational interventions that aimed to enhance co-smokers’ readiness 
to simultaneously quit tobacco and cannabis use. These web-based interventions are evaluated 
in Paper 3 using a randomized trial with pre-, post-, and 8-week follow-up assessments. 
The papers address the following research questions: 
Q1. Is there a demand for interventions that are tailored to co-smokers of tobacco and 
cannabis? (addressed in Paper 1) 
Q2. Is the cessation intervention for co-smokers of tobacco and cannabis feasible? (addressed 
in Paper 1 and 2) 
Q3. Can brief web-based interventions enhance co-smokers’ readiness to quit simultaneously 
and what kind of web-based intervention is most effective? (addressed in Paper 3) 
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Q4. How do combined interventions for tobacco and cannabis use affect substance use? 
(addressed in Paper 2 and 3) 
Q5. What has to be considered when targeting tobacco and cannabis use simultaneously? 
(addressed in Paper 1, Paper 2, and 3) 
3.2. Summary of Paper 1 
Development of an integrative cessation program for co-smokers of cigarettes and 
cannabis: demand analysis, program description, and acceptability study 
Tobacco and cannabis use are strongly interrelated, but current national and international 
cessation programs typically focus on one substance, and address the other substance either 
only marginally or not at all. Paper 1 aimed to describe the development and content of the 
first integrative group cessation program (ISCP) for co-smokers of cigarettes and cannabis. 
First, a preliminary study was carried out to investigate the demand for, and collect 
suggestions for the design of an ISCP. Therefore, expert interviews, user focus groups with 
(ex-)smokers, and an online survey were conducted. In general, the study revealed that both 
experts and co-smokers considered an ISCP to be useful but expected only modest levels of 
readiness for participation. Only half of the co-smokers responding to the online-survey 
thought that smoking tobacco and cannabis was interrelated but 68% confirmed the need of a 
dual-cessation intervention. Although only 28% felt ready to quit both substances 
simultaneously, 41% felt ready to participate at an ISCP. A logistic regression analysis 
revealed three significant predictors of readiness to quit tobacco and cannabis simultaneously: 
higher age, frequent (at least weekly) use of cannabis, and agreement with the statement 
“Cannabis is harmful to my health” were positively associated with readiness for a 
simultaneous cessation attempt. Regarding the intervention design, co-smokers of the focus 
groups stressed the importance of appropriate knowledge transfer concerning the 
interrelationship between both substances. For a group cessation intervention they suggested 
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that all participants should form a common goal for the intervention. Given that the experts 
believed that dual-cessation was more complex and demanding than single-cessation, they 
suggested that an ISCP should offer comprehensive medical, psychiatric and 
psychotherapeutic support. 
Based on the findings of the preliminary study and of previous literature, an 
interdisciplinary team developed a treatment manual for an ISCP tailored to co-smokers who 
smoke tobacco products (e.g. cigarettes, pipes) at least daily and cannabis at least weekly. 
Two local addiction treatment centres in the Swiss cities of Zurich and Winterthur offered the 
courses. At an information evening, the two course instructors who guided the particular 
course presented the course program and background information, especially stressing the 
relationship between tobacco and cannabis use and the underestimated physical harms of 
cannabis use. In order to generate a low threshold intervention, the course consisted of only 
five to six weekly group sessions, a revival meeting after approximately six weeks, and one 
individual counselling session on request. Additionally, participants received a workbook and 
a smoking diary. The intervention based on principles of MI and CBT, on self-control 
practices and on the relapse-prevention model. Furthermore, participants were encouraged to 
use NRT or varenicline. The course aimed at dual abstinence with a common quit date at the 
third course session. Simultaneous cessation was preferred to sequential in order to avoid that 
the continued smoking of one substance cues the re-use of the one that was quit first.  
During two implementation phases that lasted nine months in total, three 5-session 
courses (implementation phase 1) and four 6-session courses (implementation phase 2) were 
carried out with a total of 77 participants. At the end of treatment, 59 participants completed 
questionnaires that included items to measure the participants’ opinion towards the 
intervention. The eight course instructors received an analogous questionnaire after they had 
conducted the last course. On a scale ranging from 0 to 5 with higher values indicating more 
positive evaluations, the participants (M = 3.9, SD = 1.1) and the course instructors (M = 4.3, 
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SD = 0.5) rated the course in general positively. Both the participants (M = 4.1, SD = 1.1) and 
the course instructors (M = 4.3, SD = 0.9) particularly appreciated the module “Analysis of 
the consumption diary” which was usually accompanied by an extensive group discussion. 
Participants of the implementation phase 2 with six instead of five course sessions tended to 
higher ratings than phase 1 participants. Furthermore, participants and course instructors 
valued those modules that aimed at developing concrete strategies for simultaneous cessation. 
3.3. Summary of Paper 2 
Feasibility, safety, and initial effectiveness of an integrative group cessation intervention 
for co-smokers of tobacco and cannabis 
This study evaluated the feasibility, safety, and initial effectiveness of the ISCP, using a 
within-participants design with pre-, post-, and 6-month follow-up assessments. Two 
addiction treatment centres in Zurich and Winterthur, Switzerland, conducted seven group 
courses with a total of 77 participants. The inclusion criteria were (1) an age of 18 years or 
older; (2) daily tobacco cigarette, pipe, or cigar smoking; and (3) cannabis smoking at least 
once per week. The primary outcomes included cigarette use frequency, cannabis use 
frequency, and dual-abstinence at the 6-month follow-up assessment with 7-day timeline 
follow-back questions (Hjorthøj, Hjorthøj, & Nordentoft, 2012). Dual-abstinence was 
achieved if neither cigarette nor cannabis use was reported, and salivary cotinine was used to 
analytically verify self-reported dual-abstinence. 
Abstinence from cigarettes, cannabis, or both was reported by 41.5% of the participants 
at the end-of-treatment (EOT) and by 23.4% at the 6-month follow-up assessment. For each 
substance separately, self-reported abstinence rates were 32.5% (EOT) and 10.4% (follow-up) 
for cigarettes and 23.4% (EOT) and 19.5% (follow-up) for cannabis. Cotinine-validated dual-
abstinence was achieved by 13.0% (EOT) and 5.2% (follow-up). Generalised estimating 
equations (GEEs) revealed that tobacco use frequency (p = .001) and cannabis use frequency 
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(p < .001) decreased significantly over the study period. Furthermore, all secondary outcomes 
improved significantly over time (problem drinking: p = .003; cigarette dependence, cannabis 
use disorder symptoms, depression, anxiety: all p < .001). Among participants who quit only 
one substance no evidence of a compensatory increase in the use of the other substance was 
found. The treatment retention rate was 62.3%, and participant satisfaction at the EOT 
assessment was high. On a scale ranging from 0 (“definitely no”) to 5 (“definitely yes”), the 
majority of the 57 responding participants (33, 57.9%) chose the highest value of 5 (M = 4.2, 
SD = 1.1). Only three people reported that among their reasons for discontinuing the treatment 
was the experience of severe problems (i.e. problems with concentration and sleeping, 
depressive symptoms, or distorted perception) that emerged during their simultaneous 
cessation (attempt). We did not find evidence of hospitalisation due to course participation. 
In conclusion, the evaluated group cessation program for co-smokers of tobacco and 
cannabis is feasible and comparatively safe. Testing this interventional approach within a 
randomized controlled trial would be reasonable. Nevertheless, the finding that three 
participants experienced severe problems due to their simultaneous cessation (attempts) must 
be addressed when implementing the program in the future.  
3.4. Summary of Paper 3 
Effectiveness of different web-based interventions to prepare co-smokers of tobacco and 
cannabis for double-cessation: a three-arm randomised trial 
According to the results of the preliminary study presented in Paper 1, co-smokers’ readiness 
for simultaneous cessation of tobacco and cannabis use is only modest. Thus, the question of 
how co-smokers can be motivated for a simultaneous cessation attempt had occurred. Because 
of its easy access and ubiquitous presence, the Internet arose as a potentially effective medium 
to reach a large number of co-smokers who might be unaware of the relationship between 
their tobacco and cannabis use. We developed three web-based and fully automated 
THE PRESENT THESIS 
38 
interventions according to therapeutic approaches that are used for motivational enhancement 
in substance users. The first intervention combined the assessment of cigarette dependence 
and problematic cannabis use with personalised, normative feedback. The second intervention 
was based on principles of MI. As an active psycho-educational control group, the third 
intervention merely provided information on tobacco, cannabis, and the co-use of the two 
substances. To keep the threshold for intervention access and the study dropout rate as low as 
possible, the interventions were designed as brief single-session interventions. 
Within a randomized trial with pre-, post-, and 8-week follow-up assessments, the 
interventions were evaluated regarding their efficacy to enhance readiness to simultaneously 
quit tobacco and cannabis, as measured with a readiness ruler (Biener & Abrams, 1991). 
Secondary outcomes were cigarette and cannabis use frequency, measured at baseline and 
after eight weeks. A total of 2467 website-users were assessed for eligibility of tobacco and 
cannabis co-use and 325 participants were finally randomized to the interventions and 
included in the analyses. 
For the post-intervention assessment, GEEs revealed a significant increase in the 
readiness to quit tobacco and cannabis in the total sample, B = 0.33, 95% CI [0.10, 0.56], 
p = .006. However, this effect was not significant for the comparison between baseline and 
follow-up assessment (p = .69). Furthermore, no differential effects between the intervention 
types were found. Moreover, there were no significant intervention type or time effects for the 
frequency of tobacco or cannabis use. 
In can be concluded that, in the arising field of dual interventions for co-smokers of 
tobacco and cannabis, brief web-based interventions can increase short-term readiness to quit 
tobacco and cannabis simultaneously. However, the personalised techniques were not more 
effective than psychoeducation and the interventions did not change frequency of tobacco and 
cannabis use.  
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4. GENERAL DISCUSSION 
In the following, the results presented in the three papers will be integrated in an overall 
discussion of the research questions and methodological aspects. Finally, implications for 
clinical practice and for future research are derived based on the current findings. 
4.1. Discussion of the Major Results 
Three research articles describing the development and evaluation of web-based motivational 
interventions and a smoking cessation intervention for co-smokers of tobacco and cannabis 
constitute the basis of this thesis. These interventions are among the first that are explicitly 
tailored to co-smokers of tobacco and cannabis, a target group that has been ignored in 
intervention research so far. In the following, the studies’ results are discussed against the 
background of the research question formulated in section 3.1. 
 
Q1. Is there a demand for interventions that are tailored to co-smokers of tobacco and 
cannabis? (addressed in Paper 1) 
The preliminary study confirmed a need for interventions addressing tobacco and cannabis 
simultaneously (Paper 1). This is in line with the conclusion that the authors of recent reviews 
have drawn (Agrawal et al., 2012; Peters et al., 2012; Ramo et al., 2012). These conclusions 
were based on the finding that no such interventions exist so far and on evidence indicating 
that single-interventions tend to be less effective for co-smokers than for users of either 
tobacco only or cannabis only. The current demand analysis was the first examining the 
perceived need among co-smokers themselves and experts including practitioners, i.e. 
potential providers of such treatment. Among the reasons for the lack of combined 
interventions for tobacco and substance use is the fact that clinicians prioritized the treatment 
of non-nicotinic substance use for a long time (S. M. Hall & Prochaska, 2009). Thus, the 
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finding that the practitioners in the current demand analysis clearly perceived a need for a 
combined intervention may reflect a change in attitudes towards the combined treatment of 
tobacco and cannabis use.  
 
Q2. Is the cessation intervention for co-smokers of tobacco and cannabis feasible? (addressed 
in Paper 1 and 2) 
So far, no comparable intervention has been published and the only small pilot study that 
analysed a dual-cessation intervention was conducted in an individual setting and published 
after the implementation of the ISCP. Thus, it was necessary to first evaluate the developed 
ISCP regarding its feasibility rather than directly conducting a large scale randomized 
controlled trial to determine efficacy. Although no consensus on the evaluation of feasibility 
exists (Arain, Campbell, Cooper, & Lancaster, 2010; Bowen et al., 2010), Bowen and 
colleagues identified several indicators commonly used to measure feasibility. These are 
acceptability, demand (e.g. perceived demand and actual use), implementation (e.g. success or 
failure of execution, resources needed for implementation), practicability (e.g. efficiency, 
positive/negative effects on participants), adaptation (e.g. degree to which similar outcomes 
are obtained in a new intervention format), integration (e.g. perceived fit with infrastructure), 
expansion (e.g. fit with organizational goals and culture), and limited efficacy (e.g. does the 
program/intervention show promise of being successful with the intended population). 
Overall, the findings of the ISCP evaluation support its feasibility. Regarding 
acceptability, both participants and course instructors highly accepted the ISCP (Paper 1) and 
those participants returning the follow-up questionnaire were still satisfied with the 
intervention (Paper 2). Demand is supported by the findings of the preliminary study 
revealing that both experts and co-smokers perceived a demand for an ISCP (Paper 1, see 
discussion of research question Q1 above). Furthermore, Paper 2 illustrated that the ISCP was 
actually used by its target group. The planned sample size of 80 was reached (83 participants 
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participated in the ISCP, 6 of which were excluded from the analyses, see Paper 2). The 
implementation took place without any problems and was concluded two months faster than 
planned. Regarding practicability, the group setting as a resource saving treatment format 
turned out to be appreciated by the participants and course instructors, as indicated by the 
positive evaluation of the group discussion which took up nearly half of the time of each 
course session (Paper 1). Although at least three participants discontinued the course due to 
severe problems (i.e. problems with concentration and sleeping, depressive symptoms, and 
distorted perception), we found no evidence of hospitalisation due to course participation, 
suggesting that the intervention is considerably safe. Presumably, the advantages of outpatient 
treatment, e.g. cost-effectiveness and accessibility, outweigh adverse events as those reported 
by some participants of the ISCP. Possibilities to minimise such negative effects are discussed 
in section 4.4. The indicator adaptation is not applicable since no comparable intervention has 
been carried out so far. Concerning integration and expansion, the implementation of the 
courses in two treatment centres was successful. According to reports of the course instructors 
(not reported in this thesis), both centres previously had experienced the implementation of 
group interventions as disappointing because recruitment was difficult and treatment attrition 
high. Therefore, they were content using the ISCP and intend to implement the ISCP in the 
future. Finally, limited efficacy (in Paper 2: initial effectiveness) is supported by a retention 
rate of 62% and the findings that frequency of tobacco and cannabis use, nicotine dependence 
as well as problematic cannabis and alcohol use decreased. Furthermore, mental health 
improved over the study period (Paper 2).  
However, whether observed positive changes and the achieved abstinence rates are 
really caused by the ISCP and whether the ISCP is more effective than a single-cessation 
intervention can only be determined with a randomized, controlled study. The effect of the 




Furthermore, the generalizability of our feasibility findings is limited to the group 
setting. Also, the ISCP was developed for and implemented with adults, as was the 
intervention in the USA (Hill et al., 2013). Therefore it is not possible to draw a conclusion 
regarding the feasibility of dual-cessation interventions for adolescents. An appropriate 
intervention for this target group would have to be adapted to the particular situation of 
adolescent co-smokers. One possibility is to include the family in the treatment, as it is done 
in multidimensional family therapy (MDFT). This approach seems to produce superior 
treatment outcomes than individually-focused CBT (Liddle, Dakof, Turner, Henderson, & 
Greenbaum, 2008), in particular among youths with more severe drug use and psychiatric 
comorbidity (Henderson, Dakof, Greenbaum, & Liddle, 2010). 
 
Q3. Can brief web-based interventions enhance co-smokers’ readiness to quit simultaneously 
and what kind of web-based intervention is most effective? (addressed in Paper 3) 
The within-subjects comparison of Paper 3 revealed a significantly higher readiness to quit 
simultaneously at the post-intervention assessment compared with the baseline assessment. 
The comparison between baseline and follow-up did not show a significant time effect. These 
results indicate that the three web-based interventions are effective in increasing the readiness 
for simultaneous cessation at short-term. Furthermore, between-groups analyses showed no 
significant differences between the three interventions. However, due to the study design not 
including an assessment-only, condition effects of the assessment procedure and intervention 
effects cannot be disentangled. Section 4.2 discusses this methodological aspect in more 
detail.  
Both the lack of differences between the three types of interventions and the significant 
time effect at short-term are in line with a study on web-based interventions separately 
targeting problematic alcohol users and problematic cannabis users (Jonas et al., 2012). In this 
study, a single-session of chat-based MI was compared with a chat providing participants with 
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technical information about the baseline self-test. However, comparability with the study of 
this thesis is limited because the interventions in the study by Jonas and colleagues targeted 
only one behaviour and were not delivered in a fully automated manner. 
 
Q4. How do combined interventions for tobacco and cannabis use affect substance use 
behaviour? (addressed in Paper 2 and 3) 
While participants of the cessation intervention significantly reduced their use frequency of 
tobacco and cannabis over time (Paper 3), the within-subjects analyses of the web-based 
motivational interventions failed to reach significance (Paper 2). However, the interventions 
presented in the two papers differed regarding their goal and intensity. The web-based 
motivational interventions were very brief interventions and aimed primarily at enhancing 
readiness to quit simultaneously, whereas the ISCP supported the participants during several 
weeks including a wide range of behavioural treatment strategies promoting cessation or, if 
not possible, reduction of use. Therefore, the difference between the interventions regarding 
this outcome is not surprising. 
It cannot be excluded that external factors could also have caused the observed change 
in substance use behaviour among the ISCP participants because we did not compare the 
intervention with an assessment-only or a delayed treatment control group.  
 In general, it is difficult to compare the results presented in this thesis with other 
studies because only one other study examining an intervention for co-smokers has been 
published so far (Hill et al., 2013). The smoking cessation intervention presented in this thesis 
and its evaluation differ also from the pilot study by Hill and colleagues. For instance, the 
ISCP has been conducted in a group rather than an individual treatment setting and it has been 
evaluated with a larger sample including relevant outcomes like dual abstinence that not have 
been reported by Hill and colleagues. Regarding tobacco use outcomes, the comparability 
between the ISCP and tobacco interventions integrated in substance abuse treatments (see 
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section 2.2.4) is also limited due to the lower priority usually assigned to the integrated 
tobacco cessation compared to the primary substance participants were seeking treatment for 
(S. M. Hall & Prochaska, 2009). Furthermore, the integrated interventions were often 
conducted in inpatient settings.  
 
Q5. What has to be considered when targeting tobacco and cannabis use simultaneously?  
In the preliminary study, several suggestions concerning important issues to be considered 
when developing a combined intervention were collected a priori. In addition, Paper 2 and 
Paper 3 allow for posteriori conclusions in terms of lessons learned during the implementation 
of the interventions.  
The results of the preliminary study indicate that the recruitment strategy is crucial for a 
combined cessation intervention as both the experts and the co-smokers expected a low 
readiness to participate in such an intervention. Thus, the recruitment was planned thoroughly 
and two strategies were applied. The first was to spread the information of the new cessation 
course as wide as possible. This was mainly done by distributing leaflets and brochures and 
stimulating reports in newspapers and radio stations. The second strategy was to built 
motivation by informing about issues that were not widely known among the co-smokers 
participating in the preliminary study. That is, the strong relationship between tobacco and 
cannabis use and the potential physical harm of smoking cannabis were particularly stressed 
during the information evenings offered to potential participants. The finding, that within the 
preliminary study fewer online survey respondents had negative attitudes towards cannabis 
than towards tobacco use is in line with other studies reported in section 2.1.4 (Amos et al., 
2004; Highet, 2004; J. P. Lee et al., 2010; Sifaneck et al., 2005). However, whether the 
emphasis on these issues has influenced the recruitment success cannot be determined. 
Furthermore, a review of interventions for recruiting smokers into cessation programs 
revealed that text messages indicating scarcity of places available were an effective 
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intervention (Marcano Belisario, Bruggeling, Gunn, Brusamento, & Car, 2012). The 
information evenings during the first implementation phase of the GCP were extremely well 
frequented which might have been the result of the big media interest and the reports in 
popular newspapers. As a consequence, the available spaces actually were scarce – although a 
parallel group was spontaneously organized. This scarcity possibly influenced participation 
similarly to the study cited above.  
The results of the preliminary study also indicate that readiness to quit tobacco and 
cannabis simultaneously is modest. As this might be an obstacle both to spontaneous quit 
attempts and the participation in a combined cessation intervention, as well as to quit success, 
motivational strategies are important for combined interventions. The results of Paper 3 
indicate that web-based interventions enhance co-smokers’ readiness to quit simultaneously in 
the short-term. Furthermore, the structure of the cessation intervention also accounted for the 
need of motivation building by applying motivational strategies at the information evening 
and by setting the quit date only at the third course session. However, again it is not possible 
to determine the effectiveness of these strategies regarding participation at the intervention. 
Combined interventions should account for the complexity of changing two behaviours 
simultaneously. All three papers pointed out this issue. In Paper 1, the experts and co-smokers 
participating in the preliminary study pre-estimated that simultaneous cessation was 
especially demanding and complex. Furthermore, the analyses of the web-based interventions 
did not reveal significant reductions in tobacco and cannabis use frequency, indicating that the 
web-based interventions may have been too brief to promote behaviour change (Paper 3). 
Finally, the finding that three participants of the ISCP experienced severe problems underlines 
the complexity of simultaneous cessation (Paper 2). Prolonging the treatment is a possibility 
to address this complexity and would be in line with the evidence that the efficacy of tobacco 
interventions increases with their intensity (Fiore et al., 2008). Furthermore, a study 
comparing intensive smoking cessation with usual care for smoking cessation among alcohol-
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dependent smokers found a higher short-term smoking quit rate for the intensive intervention 
(Carmody et al., 2012). The finding that co-smokers participating in the second 
implementation phase with six instead of five course sessions rated the ISCP more positively 
additionally indicates that a longer treatment may be more appropriate (Paper 1).  
4.2. Discussion of Methodological Aspects  
An overall aspect important in all studies with co-users of tobacco and cannabis is the 
definition, the measurement, and the analyses of the term co-use. This is especially difficult 
when co-use is defined as it is in this thesis, i.e. as co-smoking of cigarettes (or similar 
tobacco products) AND cannabis (administered either with or without tobacco). One 
difficulty of this definition was that participants reporting cigarette-abstinence may still have 
been using tobacco in joints and therefore could not be defined as tobacco-abstainers. 
Although we assessed the most common way of cannabis administration, we could not 
exclude that those reporting tobacco-free administration were not using other forms of 
administration from time to time. The recent publication on routes of administration among 
the C-SURF study participants indicates that often different ways of administration are 
combined (Baggio et al., 2013). As a consequence of our definition, we also could not 
analytically verify self-reported cigarette-abstinence of ISCP participants because this would 
have resulted in false-negative testing among those who still used cannabis and administered 
it with tobacco (Paper 2). The objective validation of self-reported cannabis-abstinence 
constitutes a further problem, especially in studies of low-threshold interventions refraining 
from collecting urine samples. A further barrier to using analytical methods in validating 
cannabis abstinence was that the follow-up data was collected via post. So far, methods of 
salivary delta-9-tetrahydrocannabinol (THC) that are both valid and applicable under this 
sampling and transport conditions are lacking (D. Lee & Huestis, 2013). 
Furthermore, several methodological aspects are shared by Paper 2 and 3. First, the 
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parallel implementation of the web-based interventions and the ISCP has to be considered. It 
would have been interesting to analyse whether the web-based interventions had an influence 
on participation at the ISCP or on treatment success. Initially these analyses were planned. 
However, it was not possible to conduct them in a reliable manner because a one-to-one 
assignment of the participants of the web-based interventions to those of the ISCP was 
impossible. In order to ensure anonymity, both interventions required the participants to 
create a personal code according to a rule combining certain letters of the parents’ names and 
their own date of birth. Nevertheless, during the implementation of the ISCP it became 
evident that some participants provided different codes at different measurements although 
the combination rule was included in every questionnaire. Thus, even the matching within 
each intervention was difficult although possible. In the ISCP the groups of participants were 
small and the questionnaires could be matched according to the date they were filled in. In the 
web-based interventions study the telephone interviewers directly matched those participants 
of the web-based interventions that were followed-up via telephone calls. Those who filled 
out the online survey received the corresponding link in an email that was sent eight weeks 
after the baseline assessment. Therefore, they could also be matched according to the date the 
survey was filled out at. However, matching the participants between the interventions would 
have been unreliable. 
A further common aspect of Paper 2 and 3 has already been mentioned: Neither the 
web-based interventions nor the ISCP included an assessment-only or a delayed-treatment 
control group. Because of the brevity of the web-based interventions with a length of 18 to 29 
minutes including baseline and post-intervention assessments, an assessment-only condition 
would not have been feasible. A delayed-treatment control group, however, would likely have 
created a high attrition rate due to the low-threshold and non-binding study setting. The 
conclusion that the three web-based interventions are effective in enhancing co-smokers 
readiness to quit simultaneously therefore remains tentative. Regarding the ISCP, a control 
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group was not included because the main goal of the study was to analyse feasibility rather 
than effectiveness, as this was the first intervention of its kind. It can therefore not be 
excluded that other factors than the intervention caused the decreases in substance abuse and 
related problems and the increases in mental health that were observed during the study time. 
Finally, it has to be considered that the sample sizes in Paper 2 and Paper 3 were 
reduced through intervention drop-out and study attrition, i.e. loss to follow-up. This was 
addressed by using GEEs for the analysis of changes over time because this method does not 
require complete data on all subjects (Arndt, 2009; Twisk, 2013). As the attrition rate in the 
web-based interventions was particularly high, in Paper 3 missingness was additionally 
addressed by applying multiple imputations which take into account the uncertainty 
surrounding missing data (Arndt, 2009). By including a wide range of predictors (i.e. baseline 
variables and post-intervention variables with low rates of missingness) in the imputation 
model, missing data can be estimated more accurately (Heeringa, West, & Berglund, 2010). 
Still, the results concerning changes of readiness to quit simultaneously and substance use 
frequency between the baseline and the follow-up assessment should be interpreted 
cautiously. For several reasons, the technique of multiple imputations was not applied in the 
analyses of the ISCP (Paper 2). First, contrary to the analysis of the web-based interventions, 
the analysis of the ISCP did not include between-groups comparisons where differential loss 
to follow-up can confound results regarding intervention effectiveness. Second, due to the 
small sample size only a small number of predictors could have been included in the 
imputation model, resulting in less reliable estimations. However, by reporting abstinence 
rates determined with two methods, i.e. complete case analysis and missings being treated as 
non-abstainers, the “true” abstinence rates can be estimated. They are in between the two 
reported rates, as complete case analyses provide too positive estimations and the treatment of 
all missings as non-abstainers is a too conservative approach. 
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4.3. Implications for Clinical Practice 
The results of this thesis have several clinical implications. The most important one is that 
combined treatment of tobacco and cannabis use in adult co-smokers is feasible and is likely 
to result in reduced tobacco and cannabis use or even abstinence (Paper 2). However, 
simultaneous cessation is complex and co-smokers that attempt to quit both substances should 
be guided in both behaviour changes. Co-smokers that quit only one substance, either on their 
own or in the context of single-interventions, often report a substitution effect (Paper 1, Akré, 
Michaud, Berchtold, & Suris, 2010; Amos et al., 2004; Copersino et al., 2006; Haney et al., 
2013). As indicated by the subgroup analyses in Paper 2, participants of the ISCP that quit 
one substance successfully did not increase the use frequency of the other substance. Thus, 
targeting both substances simultaneously can avoid a substitution effect among those who quit 
only one substance successfully. It also has to be considered that few co-smokers may 
experience severe problems such as depressive symptoms during a simultaneous cessation 
attempt. Therefore, clinicians should adequately inform co-smokers in advance about 
problems that might possibly arise during simultaneous cessation and develop strategies to 
prevent such experiences or strategies to cope with them if prevention fails (Paper 2). Several 
findings of this thesis also stress the importance of intensive knowledge transfer concerning 
the relationship between both substances and the health risks of cannabis use in order to built 
up motivation for change (Paper 1, 2, 3). 
Furthermore, the evaluation of the ISCP indicates that a group setting for simultaneous 
cessation is feasible and highly accepted by participants and course instructors. This is 
reflected by the finding that both participants and course instructors especially appreciated the 
analysis of the consumption diary which was accompanied by a long group discussion 
involving exchanges of experiences and strategies between the participants (Paper 1). 
From a health systems perspective, this thesis suggests that treatment should be 
provided in closer collaboration between those who are primarily responsible for tobacco 
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interventions and those who are responsible for cannabis use treatment. The need that 
practitioners from the tobacco and the illegal drug domain break with tradition and work 
together to provide combined treatments has also been stressed by other authors (Amos et al., 
2004; Highet, 2004). 
4.4. Implications for Future Research  
This thesis suggests several possible avenues for future research in the field of combined 
interventions for co-smokers of tobacco and cannabis. In the following, several suggestions 
for future research are given with respect to design and the evaluation of interventions.  
Due to the scarcity of evidence in this field of research, much remains to be investigated 
concerning intervention design. One issue that might especially be important is treatment 
intensity. The finding that some participants reported severe problems during their 
simultaneous cessation attempt suggests that at least some participants may need more intense 
treatment. However, multiple behaviour interventions may generally require prolonged 
treatment. Thus, longer interventions should be developed and evaluated in order to find out 
whether treatments with longer duration result in increased abstinence rates. Prolonged 
interventions could support participants not only during the strongest period of withdrawal 
and early abstinence but also in consolidating their new behaviour and maintaining 
abstinence. Furthermore, no effects of the web-based interventions evaluated in Paper 3 on 
substance use were detected. Evidence suggests that the amount of web site exposure and the 
depth of tailoring web-base interventions is associated with higher rates of tobacco cessation 
(Hutton et al., 2011). Future research should therefore examine whether more intense 
motivational web-based interventions result in reduced substance use. However, it should be 
considered that longer intervention duration is likely to increase the participation threshold. 
The findings of the preliminary study indicated that co-smokers’ readiness to participate in a 
simultaneous cessation intervention might be only modest. As a consequence, the ISCP was 
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designed as a comparatively brief intervention, consisting of five sessions. After the first 
implementation phase, however, the course instructors and participants suggested to extend 
the treatment duration. Given that recruitment went without any problems during the first 
implementation phase, the course contents were then redistributed over six instead of five 
sessions. Although this might have increased the participation threshold, three out of the four 
courses conducted during the second implementation phase were still well utilised (Paper 1). 
Whether a treatment with even more sessions would still attract enough participants is not yet 
clear. Future research should try to determine what treatment intensity optimizes treatment 
effects on substance use behaviour without considerably lowering participation rate. 
A further issue that needs to be addressed is the treatment setting. The ISCP presented 
in this thesis has been carried out in a group setting whilst the only other combined tobacco 
and cannabis treatment was conducted as an individual treatment (Hill et al., 2013). It would 
be interesting to examine benefits of the group setting, for instance by including group-level 
variables in the analyses. However, sample sizes that go beyond the sample size of the 
feasibility study (77 participants) will then be needed. 
Furthermore, several questions regarding goal setting should be investigated. While the 
ISCP reported in Paper 3 had an abstinence goal for both substances and scheduled 
simultaneous cessation of both substances on a common quit date, other kinds of treatment 
goals and cessation sequences need to be examined. Although there is emerging evidence 
indicating that simultaneous cessation may predict better outcomes (Agrawal et al., 2012), 
several combinations of abstinence and reduction goals for tobacco and cannabis use are 
possible and may be worth a systematic evaluation. Furthermore, participants probably have 
their own goals that may not correspond to the official treatment goals and that may also be 
subject to changes over the treatment period. However, these individual goals are very likely 
to influence treatment success. For instance, a study that analysed the influence of personal 
goals on cannabis treatment outcomes revealed that participants were more likely to achieve 
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outcomes consistent with their personal goals (Lozano, Stephens, & Roffman, 2006). That is, 
participants with an abstinence goal were more likely to have abstinent outcomes rather than 
moderated use, and those with a moderation goal were more likely to have moderate 
outcomes rather than abstinence. 
There is also a clear need for more knowledge on how to best sequence tobacco and 
cannabis cessation in combined treatment. Thus it should be analysed whether simultaneous 
or sequential cessation is more beneficial. Regarding sequential cessation several alternatives 
are possible, depending on the substance that is stopped first and the delay after which the 
second is stopped. Probably there is no common rule and participants’ individual situation and 
preferences should be taken into account to find the best procedure. For instance, the 
sequence could be determined depending on the severity of use or on the readiness to quit 
each substance (J. J. Prochaska, Spring, & Nigg, 2008). Several studies that analysed tobacco 
cessation interventions integrated in the treatment of other substance use addressed this issue 
(e.g. Dunn et al., 2009; Mueller et al., 2012; Nieva et al., 2010). At least for alcohol treatment, 
the findings indicate that delayed tobacco cessation may be more beneficial regarding alcohol 
consumption patterns at follow-up whereas tobacco smoking outcomes did not differ 
depending on the time of intervention delivery (Joseph, Willenbring, Nugent, & Nelson, 
2004). Furthermore, studies of interventions for multiple health behaviour change indicated 
that stopping one substance successfully improves self-efficacy to also abstain from the other 
substance, arguing for sequential cessation (Noar, Chabot, & Zimmerman, 2008). However, 
due to the particular relationship between tobacco and cannabis use, findings of smoking 
cessation interventions that are combined with behaviour other than cannabis use may not be 
transferable. It also has to be considered that individualisation of the cessation procedure in 
group therapy setting may have detrimental effects on group dynamics. At least, some 
participants of the focus-group discussions of the preliminary study preferred a common goal 
(Paper 1).  
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Given the high prevalence of co-use among adolescents (Gmel, Kuendig, et al., 2013) 
and the increasing demand for treatment of cannabis use (European Monitoring Centre for 
Drugs and Drug Addiction, 2012), another important step would be to develop appropriate 
dual-interventions for co-smokers of this age.  
This thesis also suggests several methodological aspects that should be considered in 
future research when dual-interventions are evaluated. Now that first findings support the 
feasibility of dual-interventions for co-smokers (Paper 2, Paper 3, Hill et al., 2013), 
effectiveness of this approach has to evaluated by conducting randomized controlled trials. 
These could compare dual-cessation interventions with single-cessation interventions and 
control-groups. 
A further relevant issue of intervention evaluation is the development of appropriate 
methods to assess and evaluate co-use of tobacco and cannabis. As discussed in section 4.2, 
tobacco use and cannabis use are difficult to disentangle because cannabis is mostly co-
administered with tobacco. Furthermore, since verification of cannabis-abstinence cannot yet 
be done in a valid way when using saliva samples (D. Lee & Huestis, 2013), cannabis-
abstinence cannot be objectively verified in studies that apply postal data collection. Besides 
these problems, a general question arises in studies on interventions that target several 
behaviours simultaneously: How is intervention success best defined and measured? J. J. 
Prochaska, Velicer, Nigg, and Prochaska (2008) discuss several methods: a) reporting all 
changes in the individual behaviours separately; b) creating a combined statistical index of 
overall behaviour change by standardizing scores across the different behaviours; c) using a 
behavioural index that reflects the number of behaviours for which an individual has reached 
the criterion of success; d) calculating an overall factor that reflects the impact of the 
intervention (depending on intervention efficacy and participation); and e) using an 
overarching outcome measure (e.g. quality of life or cost outcomes). All methods have 
limitations, e.g. some require a consensus regarding the definition of success criteria [c)] or 
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large impact [d)] while the combined statistical index [b)] is difficult to interpret and an 
overarching outcome [e)] may be less sensitive to change. Reporting change in each 
behaviour separately [a)] increases the chance of a type I error and does not provide an 
indication of the overall impact of the intervention (J. J. Prochaska, Velicer, et al., 2008). 
Future research needs to find a consensus on how determine the overall effect of dual 
interventions for tobacco and cannabis use. Additionally, the changes in the individual 
behaviours should be reported separately to allow for comparisons with single-interventions. 
Furthermore, studies with longer follow-up periods should be conducted in order to 
examine potential long-term benefits of the dual-treatment of tobacco and cannabis.  
As summarized in section 2.1.4, evidence regarding differential effectiveness of single-
interventions for co-smokers compared to users of only one substance is still scarce and 
inconsistent (Peters et al., 2012). Thus, future single-treatment studies should consequently 
assess both tobacco and cannabis use among their participants and analyse whether co-
smokers profit comparatively less from these interventions. Of course, accounting for 
correlates of co-smoking that could confound the analysis, such as more severe use at 
baseline, is also relevant.  
Finally, future research should develop and test theories that explain the process of 
dual-cessation. Understanding the underlying processes could contribute substantially to the 
optimization of dual-interventions for co-smokers. Traditional health behaviour theories such 
as the Transtheoretical Model of behaviour change (TTM; J. O. Prochaska, DiClemente, 
Velicer, Ginpil, & Norcross, 1985), the Precaution Adoption Process Model (PAPM, 
Weinstein & Sandman, 2002), and the Theory of Planned Behaviour (TBP, Ajzen, 1991) try 
to explain health behaviour and health behaviour change. Moreover, they are often used to 
plan and evaluate health behaviour interventions. In substance use research, particularly the 
TTM is often applied despite considerable criticism (West, 2005). However, none of these 
theories does directly address multiple health behaviour change (Prochaska et al., 2008) and 
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Noar and colleagues denounce “a dearth of theorizing in the area of multiple behaviour 
change” (Noar et al., 2008, p. 275).  
4.5. Final Conclusions 
This thesis contributes to the growing body of literature on co-use of tobacco and cannabis by 
focusing on interventions tailored to co-smokers. The presented findings indicate that the 
target group of co-smokers successfully uses the group cessation intervention that is tailored 
to them. Furthermore, simultaneous treatment of tobacco and cannabis use is feasible, at least 
within the ISCP that has been evaluated here. However, the evaluation of both the web-based 
interventions and the group cessation intervention also indicates that addressing tobacco and 
cannabis simultaneously is complex and may require more intensive interventions. This may 
be especially true when sustained dual-abstinence is the main goal.  
Research on interventions for co-smokers is in its infancy. The ISCP evaluated in this 
thesis is only the second dual-intervention for co-smokers and it is the first to analyse dual-
cessation within a group setting. Furthermore, no other studies analysing web-based 
interventions for co-smokers exist so far. Thus, future studies should try to replicate the 
findings and to gain knowledge about mechanisms that underlie simultaneous cessation in 
order to develop interventions that support co-smokers in the best possible way. Conducting 
randomized controlled trials to evaluate the efficacy of dual interventions for co-smokers 
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Abstract 
Background. Tobacco and cannabis use are strongly interrelated, but current national and 
international cessation programs typically focus on one substance, and address the other 
substance either only marginally or not at all. This study aimed to identify the demand for, 
and describe the development and content of, the first integrative group cessation program for 
co-smokers of cigarettes and cannabis. 
Methods. First, a preliminary study using expert interviews, user focus groups with (ex-
)smokers, and an online survey was conducted to investigate the demand for, and potential 
content of, an integrative smoking cessation program (ISCP) for tobacco and cannabis co-
smokers. This study revealed that both experts and co-smokers considered an ISCP to be 
useful but expected only modest levels of readiness for participation. 
Based on the findings of the preliminary study, an interdisciplinary expert team 
developed a course concept and a recruitment strategy. The developed group cessation 
program is based on current treatment techniques (such as motivational interviewing, 
cognitive behavioural therapy, and self-control training) and structured into six course 
sessions. 
The program was evaluated regarding its acceptability among participants and course 
instructors. 
Results. Both the participants and course instructors evaluated the course positively. 
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Participants and instructors especially appreciated the group discussions and the modules that 
were aimed at developing personal strategies that could be applied during simultaneous 
cessation of tobacco and cannabis, such as dealing with craving, withdrawal, and high-risk 
situations. 
Conclusions. There is a clear demand for a double cessation program for co-users of 
cigarettes and cannabis, and the first group cessation program tailored for these users has been 
developed and evaluated for acceptability. In the near future, the feasibility of the program 
will be evaluated. 
Background  
Tobacco and cannabis are interrelated in a unique, multi-dimensional manner, with some 
connecting mechanisms that are distinct from the co-use of drugs in general (Agrawal et al., 
2012). Two of them are the shared route of administration (i.e. both substances are smoked) 
and co-administration (“mulling”, i.e. adding tobacco to cannabis joints, or blunts, i.e. rolling 
cannabis in cigar paper). Mulling is the most common way of using cannabis in Europe 
(Bélanger et al., 2011). Epidemiological data show that tobacco smoking is more prevalent 
among those who consume cannabis compared to the total population. In a study in the United 
States, 74% of the marijuana users smoked cigarettes compared to 29% of the nonusers 
(Richter et al., 2005). On the other hand, cannabis use is more common among tobacco 
smokers than among tobacco abstainers. In the National Survey on Drug Use and Health 
(NSDUH) in the United States, the 30 days prevalence of cannabis use was 36% among 
tobacco smokers compared to 11% among non-smokers (Substance Abuse and Mental Health 
Services Administration, 2013). In a general population survey on tobacco use in Switzerland, 
cannabis use during the 12 months before the survey was reported by 28% of the adolescents 
who smoked tobacco daily compared to 9% and 2% of the adolescents who were ex- and 
never-smokers, respectively (Radtke et al., 2011). 
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Investigations examining the initiation of use, the transition to regular use, and the 
cessation of tobacco and cannabis use exemplify this interrelation. Tobacco use can act as a 
gateway to cannabis use (Bentler, Newcomb, & Zimmerman, 2002), but the reverse, i.e. 
cannabis use acting as a gateway to tobacco use, has also been observed (Patton et al., 2005; 
Tullis et al., 2003). Additionally, the probability of a transition from occasional to regular 
tobacco smoking and nicotine dependence is higher in smokers who also use cannabis 
(Agrawal, Madden, et al., 2008; Patton et al., 2005). Similarly, (adolescent) cannabis users 
who also smoke tobacco seem to be at higher risk for regular cannabis use and cannabis 
dependence in young adulthood compared with cannabis-only users (Swift et al., 2008). 
Regarding the cessation of tobacco use, longitudinal observational studies have 
demonstrated that tobacco smokers who also consumed cannabis made fewer attempts to quit 
using tobacco (Ford et al., 2002) and were less likely to successfully quit using tobacco 
compared with tobacco-only smokers (Abrantes et al., 2009). Furthermore, cessation 
programs that exclusively address tobacco consumption appear to be less effective for 
individuals who also consume cannabis (Gourlay et al., 1994; Moore & Budney, 2001). A 
balancing effect is one problem that co-smokers may be confronted with when wanting to 
stop using only one of the substances. It has been shown that the cessation of one substance 
often co-occurs with an increased use of the other substance (Akré et al., 2010; Amos et al., 
2004; Copersino et al., 2006). These findings highlight the importance of accounting for 
concurrent tobacco and cannabis use when planning and evaluating interventions. 
Despite this evidence, current cessation programs typically focus on one substance 
while only addressing the other substance either marginally or not at all. To our knowledge, 
no integrative smoking cessation program (ISCP) targeting co-smokers of cigarettes and 
cannabis in a group setting has been designed.  
However, results of concurrent treatments of tobacco and alcohol dependence (Mueller 
et al., 2012; Nieva et al., 2010) and tobacco and illicit substance use (e.g. opiates; (Dunn et 
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al., 2009)) have been published. Additionally, some brief interventions targeting multiple 
substance use have shown promising results (Gmel, Gaume, Bertholet, Flückiger, & Daeppen, 
2013; McCambridge & Strang, 2003, 2004). These findings demonstrate that it is feasible to 
combine a tobacco cessation intervention with an intervention that targets a second substance. 
Compared with single interventions, double interventions do not necessarily overstrain 
participants and reduce abstinence rates; instead, they generate putatively better outcomes 
with regard to one or both targeted behaviours (S. M. Hall & Prochaska, 2009; J. J. 
Prochaska, 2010).  
The separate treatment histories surrounding tobacco and cannabis may be explained by 
the different legal statuses of the two substances that are often the subject of political 
discourse and election campaigns. In Switzerland for example, tobacco is categorised as a licit 
substance, while cannabis is an illicit drug. The divisions of the Swiss government that deal 
with these substances are both organisationally and financially separated from each other and, 
currently, so is the funding for prevention programs and research projects. Another 
explanation for the lack of combined treatment for tobacco and cannabis use may be the 
historical development of treatment and prevention systems in many industrialised countries. 
Treatment of cannabis dependence and co-occurring mental health problems is provided by 
the psychiatric systems of many countries. In contrast, tobacco cessation is possible without 
the involvement of psychiatrists and is part of the more general public health systems (S. M. 
Hall & Prochaska, 2009; J. J. Prochaska, 2010) that typically involve general health supply 
services. In Switzerland, health insurance coverage differs between the substances; while 
cannabis treatment in psychiatric services is covered by basic health insurance, smokers 
themselves are required to pay for nicotine replacement therapy and courses for tobacco 
cessation.  
In recent reviews, researchers have stressed the need to develop and evaluate combined 
interventions for tobacco and cannabis users (Agrawal et al., 2012; Peters et al., 2012; Ramo 
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et al., 2012). Agrawal and colleagues found evidence that dual abstinence may predict better 
cessation outcomes and therefore suggested developing out-patient treatment models 
(Agrawal et al., 2012). 
The aim of the current study was to develop an ISCP. This process was accomplished in 
three steps, which will be explicated in this report. First, a preliminary study clarified whether 
there was a demand for an ISCP. Second, after having identified the demand, explicit 
information regarding co-smokers’ attitudes towards tobacco and cannabis and the association 
between both substances was collected for use when developing an ISCP. Moreover, co-
smokers’ relevant experiences regarding quitting one or both substances simultaneously were 
collected. Third, based on the information gained during the second step, an ISCP was 
developed tailored to co-smokers of cigarettes and cannabis. This program incorporates the 
established therapeutic principles and strategies of former tobacco and cannabis cessation 
programs and takes into account reasonable concepts and ideas from the ongoing discussion 
about the mechanisms underlying the co-use of tobacco and cannabis and potential 
dependency problems. 
Methods 
Preliminary Study and Demand Analysis 
The perception of and the need for an ISCP were explored with semi-structured qualitative 
interviews with addiction experts, qualitative age-specific user focus groups, and a 
quantitative online survey designed for current and former co-smokers. Qualitative data were 
analysed according to the coding procedures of Grounded Theory (Strauss & Corbin, 1990). 
Quantitative data were examined with descriptive statistics and logistic regression analyses, 
which were conducted to identify predictors of readiness to simultaneously quit cigarettes and 
cannabis. First, bivariate logistic regression analyses were used to identify potential 
predictors. These predictors were then entered into one model. Next, non-significant variables 
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(p ≥ .05) were removed successively from the multivariate model. The resulting model was 
verified by separately adding the excluded variables to the model to account for suppressor 
effects. Only significant predictors (p < .05) were retained in the final model. In these 
analyses, only the respondents currently smoking cigarettes and using cannabis were included. 
All quantitative analyses were conducted using PASW Statistics Version 18 and 20 (SPSS 
Inc., Chicago, IL, USA). 
Expert interviews  
Twelve addiction experts participated in the semi-structured interviews about the relationship 
between tobacco and cannabis use and the demand for and possible design of an ISCP. These 
addiction experts worked in research or were practicing psychotherapy, medicine, prevention, 
or epidemiology. The majority were known local experts in tobacco and/or cannabis use. The 
experts were reimbursed with 180 Swiss Francs (corresponding to about 167 US dollars in 
February 2010 when the interviews were conducted). Most of the experts emphasised a 
substantial relationship between tobacco and cannabis use that can cause problems, especially 
in the context of cessation attempts. For example, some experts observed that individuals who 
consumed both tobacco and cannabis increased their use of one substance when attempting to 
quit the other, which could lead to elevated risk of relapse. Quitting both substances 
simultaneously might prevent this balancing effect. Thus, the experts perceived a clear 
demand for an ISCP. Despite this demand, the experts assumed that few co-smokers would be 
ready to stop their tobacco and cannabis use simultaneously because smokers often perceived 
quitting tobacco use as a “loss” and probably would not be ready to additionally “give up” 
cannabis use. 
Regarding the design of an ISCP, the experts favoured a group setting and suggested 
incorporating methods from cannabis treatment manuals into an established tobacco cessation 
program. The experts believed that integrating an additional substance into a tobacco 
cessation program would enhance its complexity (e.g. they expected a relatively high rate of 
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participants with psychiatric comorbidities such as depression). Thus, an ISCP should offer 
comprehensive medical, psychiatric, and psychotherapeutic support for participants, on-
demand additional single treatment sessions, and specific training for the course instructors 
that would aid in addressing the complexities and potential problems of double cessation.  
The experts differed in their opinions about the appropriate age range of the 
participants. However, some experts suggested that co-smokers aged 25 years and above 
should be targeted because the experts expected a higher level of readiness to participate in an 
ISCP among this age group compared with younger co-smokers. This reasoning was based on 
the common assumption that cannabis use during adolescence is transient and thus less 
problematic and on the fact that family planning usually becomes more relevant at the age of 
25 years. Two experts suggested separating groups by gender. 
Focus groups with former and current co-smokers 
The focus group discussions were conducted to gain in-depth information concerning users’ 
problems, experiences, and methods of coping with the issues that occurred during cessation 
attempts. Recruitment was organised via counselling facilities, and participants received 
financial reimbursement for participation. To be included in the focus group discussions, 
candidate participants had to self-report 1) past or current tobacco dependence, 2) past or 
current use of cannabis at least several times per week, and 3) at least one attempt to quit 
cigarette smoking, cannabis use, or both with formal treatment. As an incentive, focus group 
participants received 100 Swiss Francs in cash (corresponding to about 95 US dollars in April 
2010 when the focus groups were conducted). 
Similar to the experts, the 14 participants of the focus group discussions (10 adolescents 
aged 16 to 22 years and four adults aged 27 to 39 years) perceived a strong relationship 
between tobacco and cannabis use. Many of the participants reported experiences with the 
aforementioned balancing effect. However, the adolescents in particular demonstrated low 
willingness to quit cannabis and discussed their negative outcome expectancies concerning 
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tobacco and cannabis cessation attempts (e.g. weight gain, sleeplessness, and increased 
alcohol consumption). The participants assumed that the general willingness of co-smokers to 
quit both substances would be low. However, due to the relationship between tobacco and 
cannabis use, they considered an ISCP to be useful. 
Regarding the ISCP design, participants emphasised the importance of appropriate 
knowledge transfer concerning the interrelationship of the substances. The participants 
deemed the differences between potential participants with regard to their motivations to quit, 
aims, consumption patterns, and life situations to be relevant. Therefore, they suggested that 
all course participants should form a common goal. Furthermore, focus group participants 
indicated that there was a strong need for the development of appropriate relaxation and stress 
reduction methods. 
Online survey with former and current co-smokers 
Taking into account the information provided by the expert interviews and user focus groups, 
the online survey included questions concerning smoking behaviour, quitting experiences, and 
attitudes towards tobacco, cannabis, and an ISCP. Moreover, the online survey investigated 
the demand for an ISCP, co-smokers’ willingness to participate in such a program, and their 
readiness to quit both substances simultaneously. Former co-smokers were asked to indicate 
whether they would have been willing to participate in an ISCP and whether they would have 
been ready to quit tobacco and cannabis simultaneously. Recruitment was achieved through 
advertisements in internet forums on smoking, cannabis use, and health and via two social 
media platforms. Lotteries for a city trip, a tablet computer, and book vouchers were used to 
encourage participation. 
The online survey began with 247 respondents who met the inclusion criteria of 
smoking both tobacco and cannabis either regularly at the time of the survey (current co-
users, n = 109) or in the past (n = 138). Current co-use was defined as daily tobacco use and 
the use of cannabis during the past seven days before the survey. The survey was completed 
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by 79.4% (196/247). Data from drop-outs were excluded in an item-wise manner. There were 
no significant differences between the drop-outs and the completers regarding age 
(U = 4908.50, p = .84), sex (χ 2(1)  = 0.368, p = .64), educational level (U = 4751.5, p = .58), 
or smoking frequency (tobacco: U = 4560.0, p = .29; cannabis: U = 4616.5, p = .40).  
The respondents were between the ages of 14 and 88 years (M = 28.71, SD = 8.46), and 
44.9% (111/247) were female. More than half of the respondents had previously attempted to 
stop smoking tobacco (74.7%, 183/245) and/or cannabis (51.2%, 124/242) at least once. Of 
those who had attempted to quit tobacco, 19 respondents (33.3%) increased their cannabis use 
after their tobacco cessation. More than half (51.6%) of those who had attempted to quit 
cannabis reported an increase in tobacco use.  
Table 1. Reasons for quitting tobacco and cannabis use among online survey respondents 
(n = 219) 
Which have been or could be reasons for  
you to quit tobacco/cannabis?  
Multiple answers possible. 
n (%) of respondents who 
checked each reason for 
quitting tobacco/cannabis 
McNemar test 
Tobacco Cannabis χ2 p 
Problems with health 145 (66.2) 102 (46.6) 22.33 < 0.001 
Decreasing physical fitness 134 (61.2) 77 (35.2) 40.73 < 0.001 
Pregnancy/starting a family 87 (39.7) 73 (33.3) 4.97 0.026 
Financial reasons 70 (32.0) 57 (26.0) 2.82 0.093 
Non-smoking partner 69 (31.5) 43 (19.6) 14.20 < 0.001 
Feeling of being dependent/not free 113 (51.6) 79 (36.1) 13.28 < 0.001 
Problems with memory or concentration 37 (16.9) 112 (51.1) 62.94 < 0.001 
Problems with motivation or achievement 47 (21.5) 113 (51.6) 52.81 < 0.001 
Mental health problems 39 (17.8) 100 (45.7) 53.73 < 0.001 
Other 21 (9.6) 32 (14.6) 3.45 0.063 
Note. McNemar’s χ2 with continuity correction. 
As shown in Table 1, smokers’ potential and ex-smokers’ actual reasons for quitting differed 
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significantly according to the substance (tobacco or cannabis). Reasons for quitting tobacco 
use were related to physical health aspects, whereas the most common reasons for cannabis 
cessation were problems with memory, concentration, motivation, and achievement. 
Respondents could also specify further reasons, which were not included in the list. The listed 
reasons were quite heterogeneous. However, several respondents mentioned the lack of desire 
to smoke tobacco and/or cannabis as a potential or actual reason to quit. For tobacco use, 
several respondents listed olfactory or gustatory reasons for quitting, and for cannabis use, 
some respondents mentioned that they experienced no effects or negative effects after the use 
of the substance as a reason for quitting. 
Table 2 shows attitudes towards the potential negative effects of tobacco and cannabis 
smoking. Compared to the analogous statements for cannabis smoking, a significantly higher 
proportion of respondents confirmed the statements concerning the negative effects of tobacco 
smoking.  
Table 2. Attitudes towards tobacco and cannabis use among online survey respondents of the 
preliminary study (n = 216) 
Smoking tobacco/cannabis… Tobacco Cannabis Wilcoxon signed-
rank test 
n (%) n (%) z p 
…is harmful to my health 197 (91.2) 114 (52.8) -8.38 < 0.001 
…can cause lung cancer, heart diseases and 
other serious diseases 
190 (88.0) 122 (56.5) -7.52 < 0.001 
…is addictive 185 (85.6) 81 (37.5) -9.13 < 0.001 
…promotes premature skin aging and harms 
one’s appearance 
147 (68.1) 75 (34.7) -8.43 < 0.001 
Note. Items could be answered with “I fully agree”, “I somewhat agree”, “I somewhat disagree”, or “I fully 
disagree”, n (%) for “I fully agree” responses are displayed. 
Half of the respondents (124/247) thought that smoking tobacco and cannabis were 
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interrelated (33.6% responded “yes probably”, and 16.6% responded “yes”). Furthermore, 
67.6% (140/207) of the respondents affirmed the need for an ISCP (22.2% responded “yes”, 
and 45.5% responded “yes probably”).  
However, of those who were currently smoking tobacco and using cannabis only 27.6% 
(29/105, 95% CI [0.20, 0.37]) stated that they felt ready to quit both substances 
simultaneously (15.6% responded “yes”, and 11.0% responded “yes probably”), and 41.4% 
(36/87, 95% CI [.31, .52]) felt ready to participate in an ISCP (10.1% responded “yes”, and 
22.9% responded “yes probably”).  
Three predictors significantly predicted readiness to quit tobacco and cannabis 
simultaneously in a logistic regression analysis. Age was positively associated with readiness 
for simultaneous cessation, OR = 1.11, 95% CI [1.03, 1.19], p = .00). Furthermore, using 
cannabis at least once a week predicted a lower likelihood of feeling ready to quit compared 
with using cannabis less frequently, OR = 0.12, 95% CI [0.04, 0.40], p = .001. Finally, partial 
or full agreement with the statement “Cannabis is harmful to my health” increased the 
likelihood of readiness to quit the substances simultaneously, OR = 4.13, 95% CI [1.43, 
11.94], p = .009. 
With regard to the program design, more than 70% (127/179) of the respondents 
considered an ISCP useful for individuals between 20 and 25 years and more than half of the 
respondents found it useful for those between 15 and 20 years (101/179) and for those 
between 25 and 30 years (98/179; multiple answers possible). In general, 69.9% (137/196) of 
the respondents preferred age-separated but only 14.3% (28/196) preferred sex-separated 
groups. The majority of the respondents (66.9%, 131/196) also suggested making the groups 
accessible only to smokers of both substances.  
Conceptualisation of the Intervention  
Given that both experts and co-smokers considered a therapeutic program for co-smokers as 
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important and sensible, the development process was continued.  
The intervention development proceeded as follows: first, literature was reviewed 
concerning effective interventions for tobacco and those for cannabis. Based on these findings 
and the results of the preliminary study, an interdisciplinary expert team was composed of 
three psychologists, one social education worker, and three psychiatrists developed the group 
intervention. The team members had experience (and expertise) in research, therapeutic 
practice (single and group interventions for tobacco, alcohol, and illegal drugs), and/or the 
development of intervention programs for the treatment of substance abuse. The program 
development was an incremental and iterative process that provided the team members with 
multiple opportunities for feedback. The experts met eight times during the seven months 
before the beginning of the course. During and after the first implementation phase, the 
experts held two further meetings to adapt the manual for the second implementation phase. 
Additionally, a thorough recruitment strategy was designed to reach as many co-
smokers as possible and motivate them to participate in the ISCP. The recruitment process 
was conceptualised as an integral part of the ISCP and acted as an intervention in and of itself. 
Therefore, this recruitment strategy will be described in detail in the following chapter about 
the ISCP. 
After the first implementation phase, the intervention was slightly refined based on the 
feedback of the course facilitators, some of whom were also part of the expert team. Given 
that there were only minor changes (i.e. the addition of a sixth course session that did not add 
content, as it only redistributed the course contents over six instead of five sessions), in the 
following chapter not both versions are described but only the adapted, second version.  
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Description of the Integrative Cessation Program for Co-Smokers of Cigarettes and 
Cannabis 
Recruitment strategy  
The recruitment strategy was planned extensively given that both the experts and focus group 
participants anticipated in the preliminary study that co-smokers would only show modest 
willingness to quit their tobacco and cannabis use simultaneously and to participate in an 
ICSP. To reach as many co-smokers as possible, information about the new course was spread 
via different channels. 
First, a website (www.i-cut.ch) consisting of two parts was designed. The first part 
provided information about the course (i.e. content, structure, and dates) and the possibility to 
register for an information evening. The second part aimed to enhance co-smokers’ 
motivation to quit simultaneously and participate in the ISCP, primarily by providing 
information, offering a self-assessment with normative feedback, and using techniques 
adapted from motivational interviewing (Miller & Rollnick, 2002).  
During the next step, a press release was issued. This step occurred only once at the 
beginning of the study and attracted a great deal of interest, which resulted in several reports 
in local newspapers and on radio and TV stations. Counselling centres for addiction 
prevention and treatment, psychiatrists, and health (care) centres in the canton of Zurich and 
bordering cantons helped spread flyers and leaflets that referred to the website for more 
information. Additionally, two social media platforms and an advertisement in the online 
edition of a popular free newspaper were used for online recruitment, also referring to the 
program website for more information. 
The final step involved planning an information evening. Interested co-smokers could 
attend it without any obligation to participate in the course. The information evening provided 
the opportunity to ask questions that were answered by the course instructors, who introduced 
themselves and the course program and presented some background information. As central 
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issues, they emphasised the association between tobacco and cannabis use and the potential 
physical harm of cannabis use, which was underestimated by co-smokers in the preliminary 
study. Additionally, instructors mentioned that co-smokers could participate together with co-
smoking friends and partners to start the behavioural change together and support one 
another. 
Course setting 
Consistent with the findings from the preliminary study, the expert team considered an 
outpatient group-setting with 8 to 12 co-users of tobacco (who smoked at least one cigarette 
per day) and cannabis (who smoked at least once a week) per group as appropriate. The 
group-setting was preferred due to several general advantages of group therapy, such as cost-
effectiveness (fewer treatment personnel are needed) and interpersonal processes (e.g. peer 
support and peer pressure) (Treatment Center for Substance Abuse & Therapy, 2005). 
Additionally, in this new field of dual cessation of tobacco and cannabis use, the opportunity 
of group participants to share cessation experiences and strategies was considered especially 
important.  
Given that the co-smokers in the preliminary study preferred age-specific groups, we set 
the minimum age for participation in the ISCP at 20 years. Adolescents were excluded from 
this first version of the intervention for two reasons. First, being younger was associated with 
a decreased readiness to quit tobacco and cannabis simultaneously among the online survey 
respondents of the preliminary study. This finding is in line with the assumption of some of 
the interviewed experts in the preliminary study who expected greater readiness to participate 
among co-smokers aged 25 years and above. Second, an effective ISCP for adolescents 
should presumably differ from an ISCP designed for adults; for example, an ISCP for 
adolescents should account for school and family problems. Thus, the expert team decided to 
develop a basic program version for adults that could be adapted for adolescents if the basic 
version proved to be feasible. Separating groups by gender was considered but deemed to be 
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unfeasible due to the expected low number of co-smokers who were ready for participation. 
Furthermore, the online survey respondents in the preliminary study clearly preferred age-
specificity to gender-specificity.  
Two local addiction treatment centres in the Swiss cities of Zurich and Winterthur 
offered the courses. Each course was guided by two course instructors, at least one of whom 
had to be a psychiatrist to guarantee the offer of prescription pharmacotherapy to reduce acute 
withdrawal symptoms or eventual exacerbations of severe psychiatric symptoms. The second 
instructor had to have experience in treating tobacco or cannabis smokers and could be from a 
different profession. The members of the expert team either guided the course sessions 
themselves or trained additional instructors to do so. All instructors received a therapist 
manual containing instructions for guiding the sessions and the information that was provided 
to the participants in their workbook (see below). 
Course structure, content, and goals 
The experts interviewed during the preliminary study recommended using an established 
tobacco cessation program as the basis for the ISCP and combining it with cannabis-specific 
elements. We therefore utilised parts of the group tobacco cessation course used by the UK's 
leading charity for gay men's health (GMFA), which was evaluated by Harding and 
colleagues (2004) and with which we were familiar, given that we culturally adapted and 
scientifically evaluated this program for Switzerland. We integrated elements from cannabis 
interventions that were ongoing under the supervision of members of the expert team. The 
resulting course was structured into six weekly sessions and one revival meeting that occurred 
approximately six weeks after the last session (Figure 1). Given anticipated recruitment 
problems, the expert team chose a small number of sessions to generate a low-threshold 
intervention. Each of the sessions lasted between 90 and 120 minutes. Additionally, course 




Figure 1. Course structure, content, and techniques of the integrative cessation program for 
tobacco and cannabis co-smokers. 
Subsidiary elements of the course sessions were a smoking diary and workbook which were 
introduced and distributed to the participants during the first session. The workbook contained 
background information, an overview of the course structure and content, and work sheets to 
reflect on personal reasons for cessation and develop and write down personal strategies. The 
smoking diary was a small notebook that could easily be carried to constantly monitor 
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consumption and thoughts, feelings, and actions associated with the use of one or both of the 
substances. The notebook should promote vigilance and self-examination. Furthermore, 
participants measured their expired carbon monoxide at every session to receive an immediate 
objective feedback on their therapy progress and for later program evaluation. They could 
enter their individual values in their notebooks and thereby monitor the changes in the values. 
The main goal of the intervention was dual abstinence of tobacco and cannabis. The 
instructors promoted moderation of tobacco and/or cannabis use, for example, reducing 
smoking frequency or changing to a less harmful method of administration (e.g. consuming 
cannabis orally based on medical cannabis use recommendations for severe treatment resistant 
diseases) only when participants failed to quit several times during the course. This was done 
to avoid course dropout. Regarding the cessation sequence of tobacco and cannabis, the expert 
team supported a simultaneous cessation with one fixed quit date (Quit Day), when the 
participants were required to stop their tobacco and cannabis use, which is in line with 
Agrawal’s suggestions (Agrawal et al., 2012). Before that date, participants could either 
maintain their normal use of tobacco and cannabis or start to reduce or stop one or both 
substances. Apart from the importance of having a common goal, i.e. stopping the use of both 
substances on a fixed quit date (at the latest) to foster group dynamics, this procedure was 
chosen for several reasons. First, the strong association between tobacco and cannabis use, in 
that each substance may act as a behavioural cue for the other (Agrawal & Lynskey, 2009a), 
suggests that using neither substance is likely the easiest manner of quitting. In addition, this 
strategy has the advantage of experiencing only one withdrawal phase. Withdrawal symptoms 
may be stronger for the cessation of both substances compared with the symptoms for each 
substance alone, yet evidence suggests that this difference occurs for only a short duration and 
varies substantially between individuals (Vandrey et al., 2008). For some quitters, withdrawal 
during dual abstinence may even be less severe than withdrawal from each substance 




The course was primarily based on principles of motivational interviewing (Miller & 
Rollnick, 2002), self-control practices (Sobell & Sobell, 1993), the relapse-prevention model 
(Marlatt & Donovan, 2005), and methods used in cognitive behavioural therapy that have 
been shown to be effective in the cessation of tobacco (Health et al., 2008) and cannabis 
(Budney et al., 2007; Sobell, Sobell, Wagner, Agrawal, & Ellingstad, 2006; Stephens et al., 
2006). 
Although most of these principles and techniques were applied throughout the whole 
duration of the course, the emphasis on the application of each principle differed according to 
the Transtheoretical Model of Behaviour Change (James O. Prochaska & DiClemente, 1983). 
Consequently, motivational enhancement strategies predominated in the early sessions of the 
intervention to address participants’ ambivalence about quitting and strengthen their 
motivation to change. In the following sessions, self-control practices were highlighted, such 
as an analysis of one’s own smoking behaviour with the help of the smoking diary. After the 
Quit Day, relapse prevention was the focus; relapse prevention focused on the development of 
personal strategies to avoid or cope with tobacco and cannabis use triggers. 
Additionally, participants were encouraged to use medications that are typically used as 
first-line medications to increase long-term tobacco abstinence (Health et al., 2008). As some 
negative outcomes have been observed in bupropion studies with cannabis users (Haney et al., 
2001; Neumann, Livak, & Paul, 2004), course instructors recommended varenicline and 
nicotine replacement therapy. Instructors provided information about these medications 
during the informational evening, handed out leaflets that participants could take home, and 
indicated the corresponding information in the workbook that every participant received at the 
start of the course.  
The intervention sessions that followed the information evening occurred in a group 
course setting. A meaningful part of every session was the group discussion. In these 
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discussions, the participants could share experiences and problems, and support was provided 
both among the participants and from the instructors to the participants (i.e. intra-treatment 
support). Confidentiality was ensured, and instructors placed great value on providing an 
open, non-judgemental atmosphere. Additionally, the instructors promoted the formation of 
small quit teams, i.e. subgroups of two or three participants who supported each other, 
especially between the course sessions, such as during episodes of strong craving. 
Engagement in a Quit Team was optional and the formation and organization of the Quit 
Teams was not guided by the course instructors. 
Acceptability Study of the Integrative Cessation Program 
We investigated the acceptability of the intervention among the participants and course 
instructors. Further analyses of smoking-related outcomes and utilisation will be conducted 
with the follow-up data in the near future. 
Sampling and recruitment 
Course participants were recruited with the above-mentioned methods. To be included in the 
intervention, participants had to use cannabis at least weekly, smoke tobacco (in addition to 
any tobacco used in joints) daily, be at least 18 years old, and be German literate. Participants 
were not reimbursed, but participation was free, which may have been attractive because, in 
Switzerland, tobacco cessation programmes usually require payment from the participants 
themselves. 
Recruitment of course instructors began within the expert team that developed the 
intervention. As mentioned above, some experts also acted as course instructors. The experts 
also trained co-workers from their institutions to guide the courses. 
Measurements and analyses 
At the end of treatment, participants completed questionnaires that they received either at the 
end of the last session or by mail if they missed the last session. The questionnaire contained a 
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set of items that measured the participants’ opinions toward the intervention in general and 
toward several components of the intervention. The instruction for the general items began as 
follows: “How would you evaluate the course regarding…”. The instruction for the course 
component items began as follows: “How helpful were the following components for you?” 
All items were rated on a scale from 0 to 5, and higher values indicated more positive 
evaluations.  
The course instructors received an analogous evaluation form after they had conducted 
the last course and indicated to what extent the course components were helpful to the 
participants. 
In addition to descriptive statistics, the ratings for the general items were compared 
between participants of the first (five course sessions) and second implementation phases (six 
course sessions) using Mann-Whitney U tests. This comparison was not applied to the 
specific course components because their contents did not differ between the two phases.  
Ethical Approval 
This intervention study was performed in compliance with the Declaration of Helsinki and 
was reviewed by the Ethics Committee of the Canton of Zurich, which did not declare any 
objections (KEK-StV-Nr.23/11). Participants signed an informed consent form prior to the 
first group therapy session.  
Results 
Sample Characteristics 
Over nine months, a total of 77 co-smokers participated in seven groups with six to 13 
participants each. Of these participants, 59 (76.6%) answered at least one item of the course 
evaluation. Of these 59, 31 participated during the first and 28 during the second 
implementation phase. The majority of the respondents (71.2%) were male, their mean age 
PAPER 1 
76 
was M = 34.0 (SD = 8.1) years, and most (84.7%) were Swiss. Regarding educational 
attainment, 33.9% had a university degree, 51.5% had completed secondary education (the 
majority of these participants had finished an apprenticeship), 5.1% had finished primary 
school, 3.4% had no degree, 3.4% had a degree not listed, and 1.7% did not answer this 
question. In addition to the participants, all course instructors (N = 8, 3 females) completed 
the evaluation form.  
Participants’ and Course Instructors’ Evaluations of the Intervention  
Overall, the course was rated positively by the participants (M = 3.9, SD = 1.1) and course 
instructors (M = 4.3, SD = 0.5). Regarding its comprehensibility, participants and course 
instructors evaluated the course very positively (M = 4.5, SD = 1.0 and M = 4.3, SD = 0.7, 
respectively). The ratings of the courses’ atmosphere were comparatively high (participants: 
M = 4.3, SD = 1.1; course instructors: M = 4.5, SD = 0.5). Participants rated the opportunity to 
openly discuss illegal issues particularly high (M = 4.6, SD = 1.0), and the course instructors 
also provided high ratings on this measure (M = 4.3, SD = 0.7). As displayed in Table 3, 
compared to the ratings of the phase 1 participants, the ratings of the phase 2 participants 
tended to be higher across all general items. These differences were statistically significant for 
the overall evaluation and the evaluation of comprehensibility. 
Table 3. General course evaluations from the participants of implementation phases 1 
(n = 31) and 2 (n = 28) 






   M (SD) M (SD) U p 
…overall 3.6 (1.1) 4.1 (1.0) 306.0 .041 
…regarding its comprehensibility 4.2 (1.2) 4.8 (0.5) 258.5 .018 
…regarding the atmosphere 4.1 (1.2) 4.5 (0.9) 290.5 .100 
…regarding the possibility to openly discuss 
illegal issues 
4.4 (1.1) 4.8 (0.7) 302.5 .100 
Note. Items were answered on a scale ranging from 0 (not good at all) to 5 (very good). 
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Table 4. Course participants’ (n = 56) and course instructors’ (n = 8) evaluations of the 
course components 
How helpful were the following components  
for you/for the participants?	  
Participants	   Course instructors	  
	   	  M (SD)	   M (SD)	  
Information evening	   3.6 (1.5)	   4.3 (1.0)	  
Quiz	   3.3 (1.4)	   4.0 (1.3)	  
Pro & Con	   3.5 (1.4)	   4.0 (0.8)	  
Analysis of consumption diary/group discussion	   4.1 (1.1)	   4.3 (0.9)	  
Finding alternative rituals	   3.8 (1.3)	   4.4 (0.5)	  
Dealing with withdrawal symptoms	   3.8 (1.4)	   4.4 (0.5)	  
Goal setting	   3.6 (1.4)	   4.0 (0.8)	  
Handling of high-risk situations	   3.8 (1.2)	   4.3 (0.5)	  
Dealing with craving	   3.7 (1.2)	   4.6 (0.5)	  
Adaptation of personal strategies	   3.4 (1.3)	   4.0 (0.9)	  
Dealing with lapses	   3.7 (1.3)	   4.1 (0.6)	  
Handling of social risk situations (Saying “No”)	   3.2 (1.4)	   3.6 (0.9)	  
Preserving achievements	   3.4 (1.3)	   3.6 (0.9)	  
Participants’ workbook	   3.2 (1.4)	   3.6 (1.0)	  
Consumption diary	   3.3 (1.4)	   3.4 (0.9)	  
Carbon mononxide measurement	   3.7 (1.5)	   4.5 (0.8)	  
Quit Team1	   2.4 (1.7)	   3.3 (1.0)	  
Note. Items were answered on a scale ranging from 0 (not helpful at all) to 5 (very helpful). 1Only the ratings of 
the 38 participants who were member of a Quit Team are displayed. 
Table 4 summarises the participants’ and course instructors’ evaluations of the different 
course components. Participants particularly appreciated the analysis of the consumption 
diary (M = 4.1, SD = 1.1), which was usually accompanied by an extensive group discussion 
involving exchanges of experiences between the participants. With the exception of “handling 
of social risk situations”, participants and course instructors provided high ratings of all the 
modules that aimed at developing concrete, personal strategies for handling problems that can 
occur during smoking cessation. Course instructors also considered the carbon monoxide 
measurement as helpful for the participants. Of all the course components, the Quit Teams 
which were an optional element received the lowest ratings from both the course instructors 
(M = 3.3, SD = 1.0) and the 38 participants who indicated that they have been a member of 
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such a Quit Team (M = 2.4, SD = 1.7). 
Discussion  
This study describes the development and content of the first integrative group cessation 
program for co-smokers of tobacco and cannabis. The program was developed after a 
preliminary study revealed that both experts and co-smokers of cigarettes and cannabis 
demanded combined interventions to address simultaneous tobacco and cannabis cessation. 
This result is consistent with previous theoretical discussions (Agrawal et al., 2012; Peters et 
al., 2012; Ramo et al., 2012). 
During the preliminary study, experts stressed the multi-dimensional relationship 
between tobacco and cannabis use that is particularly evident during cessation attempts. Many 
consumers reported experiencing the balancing effect mentioned by the experts (i.e. the 
increased use of the other substance after quitting the first substance). However, among the 
queried co-smokers, there was only a modest level of readiness to quit tobacco and cannabis 
simultaneously and of readiness to participate in an ISCP that addressed both substances at 
the same time. Many co-smokers were not aware of the relationship between tobacco and 
cannabis use or the harmful physical health consequences of smoking cannabis. This lack of 
awareness might explain the modest level of readiness to quit simultaneously. To overcome 
this lack of awareness and knowledge, the interdisciplinary expert team developed a 
participant recruitment strategy that was an integral part of the ISCP. 
The recruitment for the courses was a success because 77 participants were recruited, 
and seven courses were accomplished within a relatively short time frame of nine months. 
This success may be attributable to two factors. First, course participation was free of charge 
because the ISCP was still in development. In Switzerland, participants are usually required to 
pay for their own participation in tobacco cessation programs. Thus, participation rates may 
change when the program cannot be offered free of cost. Second, after the press release and a 
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report that appeared in a common free commuter newspaper at the beginning of the first 
implementation phase, participation rates for the information evening and the course itself 
were especially high. Because this strategy cannot be applied regularly, it is necessary to 
switch to appropriate alternatives in the future. In Switzerland, these alternatives could 
include regular advertisements in the two most common commuter newspapers, which reach a 
large part of the population. 
According to their evaluations of the course, both the participants and the course 
instructors found the ISCP highly acceptable. Because the items measuring the general 
acceptance of the course were rated more positively by the participants of the second 
implementation phase, a course length of six, rather than five, sessions may be more 
appropriate. The finding that participants especially appreciated the group discussions 
indicates that group settings are appropriate for targeting co-smokers of tobacco and cannabis. 
Furthermore, participants and course instructors valued those course modules that aimed at 
developing strategies which can be applied when quitting tobacco and cannabis use. 
Additionally, the course instructors considered the carbon monoxide measurements to be 
helpful. Thus, these measurements should remain part of the intervention when the scientific 
evaluation is completed and biochemical validation is not needed any longer.  
The Quit Teams were the least appreciated course element and only two thirds of the 
participants engaged in a Quit Team. Possibly the participants felt no need of this optional 
buddy support system because the group setting provided sufficient social support. Thus, 
exclusion of the element of Quit Teams could be considered for a future version of the 
program. This conclusion is supported by two studies which show that buddy systems provide 
an additional benefit in an individual smoking cessation setting (West, 2005) but not in a 
group setting (May, West, Hajek, McEwen, & McRobbie, 2006). 
The ISCP developed in this study combines two substances in one cessation program 
and connects professionals from general health provider services and psychiatric services. 
PAPER 1 
80 
Consequently, the professionals from these services will learn and potentially benefit from 
their complementary knowledge and experiences. However, beyond this intervention, policy 
makers should be sensitive to the issue of tobacco and cannabis co-use. Furthermore, the 
treatment of co-use should be implemented in the health care system and should be covered 
by existing basic health insurance. The public health approach of Screening, Brief 
Intervention, and Referral to Treatment (SBIRT) could be applied to the co-use of tobacco 
and cannabis. Thus, screening for tobacco use in primary care settings could be extended to 
include screening for co-smoking. Depending on the severity of co-smoking and the 
willingness to quit, practitioners could then provide information and advice and refer co-
smokers to targeted interventions such as the one presented here. Proactive strategies like this 
may be capable of reaching a broad range of co-smokers and prevent the intake problems that 
the ISCP might face when it will be conducted without the media interest that surrounded its 
first implementation. Historical precedents, such as ignoring cannabis in tobacco cessation 
programs and vice-versa and the use of cigarettes as reinforcers in psychiatry (S. M. Hall & 
Prochaska, 2009; J. J. Prochaska, 2010), will hopefully become issues of the past. 
However, the co-use of tobacco and cannabis should not only be addressed in treatment 
but also in prevention. According to the findings of our preliminary study, there is a lack of 
knowledge about the relationship between tobacco and cannabis among co-smokers. It is 
likely that smokers who only use tobacco or cannabis are not aware of this issue, and it is 
possible that increased awareness would help to prevent the initiation of the use of the second 
substance among these smokers. Thus, information about the problems associated with co-
smoking should be spread, especially among adolescents and young adults. 
One limitation of this study is that the online survey of former and active co-smokers 
was conducted using a convenience sample with a wide age range, those data are based on 
self-reports and retrospective cessation attempt reports. Furthermore, it is difficult to 
disentangle the reasons for the differences in the general evaluations of the course between 
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the first and the second implementation phases. Course length may be one reason, but other 
factors, such as the number of participants in the courses and the identities of the course 
instructors, also varied between implementation phases. 
Currently, we are conducting a thorough feasibility study on the ISCP and expect to 
have the results of the follow-up data in the autumn of 2013. More details on this feasibility 
study are provided in the study’s entry at Current Controlled Trials (ISRCTN15248397).  
 Conclusions 
The proposed intervention for co-smokers of tobacco and cannabis is important because it is 
the first group cessation program targeting these two interrelated substances simultaneously. 
The developed ISCP integrates the opinions of both users and experts, established therapeutic 
principles, and the strategies of former tobacco and cannabis cessation programs. This 
intervention also takes into account reasonable concepts and ideas that have emerged from on-
going discussions about the underlying mechanisms and relationships between cannabis and 
tobacco use, such as the common route of administration (Agrawal et al., 2012). To prevent 
one substance from acting as a behavioural cue for the other (Agrawal & Lynskey, 2009a), 
participants are expected to quit both substances simultaneously. Preliminary results show 
that the developed ISCP was well accepted among the participants and the course instructors. 
The group discussions and the development of personal strategies for the dual cessation of 
tobacco and cannabis use were particularly appreciated. These promising results also 
underline the high acceptance of the ISCP among the co-smokers, who, for the first time, had 
access to a group intervention especially targeted to them.  





PAPER 2. Feasibility, Safety, and Initial Effectiveness of an Integrative 
Group Cessation Intervention for Co-Smokers of Tobacco and Cannabis 
Becker, J., Haug, S., Kramer, T., and Schaub, M. P. 
Abstract 
Aims. To evaluate the feasibility and initial effectiveness of an integrative group cessation 
program for co-smokers of tobacco and cannabis 
Design. Feasibility study using a within-participants design with pre-, post-, and 6-month 
follow-up assessments 
Setting. Two addiction treatment centres in Zurich and Winterthur, Switzerland 
Participants. A total of 77 adults who used cannabis at least once per week and tobacco (i.e. 
cigarettes or similar products) at least once per day  
Measurements. The primary outcomes included cigarette-use frequency, cannabis-use 
frequency, and dual-abstinence at the 6-month follow-up assessment. 
Findings. 41.5% and 23.4% of the participants reported abstinence from cigarettes, cannabis, 
or both at the end-of-treatment and the 6-month follow-up assessment. The separate, self-
reported abstinence rates for cigarettes and cannabis were 32.5% and 23.4% (end-of-treatment 
assessment) and 10.4% and 19.5% (follow-up). Cotinine-validated dual-abstinence was 
achieved by 13.0% (end-of-treatment) and 5.2% (follow-up). Generalised estimating 
equations revealed that tobacco-use frequency (p = .001) and cannabis-use frequency 
(p < .001) decreased significantly over the study period. Furthermore, all secondary outcomes 
improved significantly over time (problem drinking: p = .003; cigarette dependence, cannabis 
use disorder symptoms, depression, anxiety: all p < .001). Among participants who quit only 
one substance we did not find evidence of a compensatory increase in the use of the other 
substance. The treatment retention was 62.3%, and participant satisfaction was high. Only 
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three people discontinued their participation due to severe problems that emerged during the 
treatment. 
Conclusion. The evaluated group cessation program for co-smokers of tobacco and cannabis 
is safe and feasible. 
Introduction  
Tobacco smoking is among the three leading risk factors for the global disease burden (Lim et 
al., 2012). Cannabis use is associated with a range of problems including those related to 
mental and physical health, cognition, and educational outcomes (Caldeira et al., 2012; W. 
Hall & Degenhardt, 2009). Both substances are often used concurrently. Tobacco smokers are 
more likely to use cannabis compared with non-smokers (SAMHSA, n.d.) and vice versa 
(Richter et al., 2005). The mechanisms linking these two substances most likely extend 
beyond a shared vulnerability and the co-use of substances in general (Agrawal & Lynskey, 
2009a). Among these connecting mechanisms are the shared route of administration (i.e. both 
substances are typically smoked) and co-administration (e.g. tobacco is added to cannabis 
joints in a process known as “mulling”) (Agrawal et al., 2012). In Switzerland, 90% of 
cannabis users smoke joints mixed with tobacco (Baggio et al., 2013). 
This strong relationship between tobacco and cannabis use is also relevant in the context 
of cessation. Epidemiological evidence shows that co-smokers make fewer attempts at 
quitting tobacco use compared with tobacco-only smokers (Ford et al., 2002) and are less 
successful at quitting (Abrantes et al., 2009). Compared with tobacco-only smokers, co-
smokers have poorer outcomes when participating in tobacco-cessation interventions 
(Gourlay et al., 1994). Correspondingly, cannabis-dependence treatments are less effective 
among individuals who also smoke tobacco (de Dios et al., 2009; Moore & Budney, 2001). 
Moreover, a laboratory study of non-treatment-seeking marijuana users revealed that co-
smokers of cigarettes were more likely to relapse after a phase of cannabis abstinence 
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compared with non-cigarette smokers (Haney et al., 2013). Smoking cigarettes is assumed to 
provide behavioural and physiological cues for cannabis smoking and vice versa, which may 
explain the increased probability of relapsing among co-smokers (Agrawal et al., 2012; 
Moore & Budney, 2001). In line with this hypothesis, a study analysed adolescents in 
substance-abuse treatment and found that never-smokers and those non-smokers who quit 
using tobacco during their marijuana treatment had a lower risk of marijuana relapse than 
those who continued or initiated tobacco smoking during treatment (de Dios et al., 2009). 
Despite the strong relationship between these substances, current interventions typically 
target only one substance while addressing the other marginally or not at all. The historical 
development of the treatment and prevention systems in many industrialised countries might 
explain the lack of combined interventions. While cannabis dependence is usually treated in 
the psychiatric care system, interventions for tobacco users are part of the general public 
health system (S. M. Hall & Prochaska, 2009; J. J. Prochaska, 2010). Recently, several 
reviews and a demand analysis identified a need for interventions tailored to co-smokers of 
tobacco and cannabis (Agrawal et al., 2012; Becker et al., 2013; Peters et al., 2012; Ramo et 
al., 2012). To date, one small pilot study evaluated individual cognitive behavioural therapy 
combined with nicotine replacement therapy (NRT) for co-occurring nicotine and cannabis 
dependence (Hill et al., 2013). The seven participants who completed the intervention reduced 
their tobacco use while maintaining their cannabis use level. Similarly, tobacco smoking 
cessation interventions integrated in treatments of alcohol or opioid dependence have 
achieved positive results (Dunn et al., 2009; Mueller et al., 2012; Nieva, Ortega, Mondon, 
Ballbè, & Gual, 2011), which indicates that tobacco cessation interventions do not undermine 
other substance abuse treatments. Instead, dual treatment programs generate putatively better 
outcomes with regard to one or both targeted behaviours (Baca & Yahne, 2009; S. M. Hall & 
Prochaska, 2009; J. J. Prochaska et al., 2004). 
The current study aimed to test the feasibility, safety, and initial effectiveness of a group 
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cessation intervention for co-smokers targeting tobacco and cannabis use simultaneously. This 
study is the first to evaluate these aspects with regard to the dual-cessation of tobacco and 
cannabis use with an appropriate sample size and in a group setting. Furthermore, it is a 
novelty to examine dual abstinence from tobacco and cannabis. 
Methods 
Study Design and Procedure 
This study used a within-participant design with pre-, post-, and 6-month follow-up 
assessments to evaluate the feasibility of an integrative group cessation intervention that 
targeted co-smokers of tobacco and cannabis. Two addiction treatment centres in Zurich and 
Winterthur, Switzerland, offered the courses between January and October 2013. The Ethics 
Committee of the Canton of Zurich reviewed and approved this study (KEK-StV-Nr.23/11), 
which was designed in accordance with the Helsinki declaration. All participants provided 
written informed consent. The study is registered at Current Controlled Trials 
(ISRCTN15248397). 
Baseline data were collected via questionnaires administered during an information 
evening or via the post for participants who did not attend the information evening. 
The end-of-treatment (EOT) assessment was conducted during the last session of the 
course. Participants completed a questionnaire and provided a saliva sample. To maximise 
response rates, we attempted to collect data from individuals who had discontinued treatment. 
Therefore, these individuals received the questionnaire and the salivette for the saliva sample 
via the post. Participants who did not return the questionnaire were contacted via telephone or 
e-mail and motivated to complete the questionnaire. If contact was not established or the 
participants reported that they did not receive or lost the questionnaire, then we resent the 
questionnaire. When the reminders were unsuccessful, participants received a brief version of 
the questionnaire that only assessed the primary outcomes.  
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The follow-up measurement was conducted six months after the designated quit date. 
All participants received a questionnaire and a salivette via the post. The measurement 
procedure was comparable with the EOT assessment, the only difference being that we resent 
the questionnaire up to three times before using brief online or phone questionnaires. 
Participants who did not complete the intervention were additionally contacted by phone or e-
mail to assess their reasons for discontinuation. Moreover, 500 Swiss Francs were raffled to 
one of the participants who returned their completed questionnaire and saliva sample. 
For recruitment, a press release announcing the intervention and the accompanying 
study was issued via local newspapers, television, and the radio to recruit participants. In 
addition, leaflets and brochures were distributed. Two social media platforms and an 
advertisement in the online edition of a popular free newspaper were used to recruit online. 
All recruitment methods referred potential participants to the intervention’s website for more 
information. Finally, an information evening was offered. The publication regarding the 
development of the intervention provides a detailed description of the recruitment process 
(Becker et al., 2013).  
Participants  
The inclusion criteria for study participation were (1) an age of 18 years and older; (2) daily 
tobacco cigarette, pipe, or cigar smoking; and (3) cannabis smoking at least once per week. 
The exclusion criteria included (1) a current, serious psychiatric illness or a history of 
psychosis, schizophrenia, or bipolar type I disorder; (2) other smoking cessation treatment at 
study entry; and (3) an inability to read or write in German.  
A total of 104 people were screened for eligibility. Of these, 12 declined to participate, 
six provided informed consent but never appeared at a course session, and three were 
excluded from participation because they no longer smoked both substances. Of the 83 
participants who began the intervention, four participants were admitted to attend the courses 
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but not included in the study because they smoked cannabis less than once per week (n = 2) or 
were in treatment for psychosis (n = 2). Two participants were retrospectively excluded from 
the study: One participant admitted during the study that she had already quit using cannabis 
prior to the baseline assessment; the other participant did not return their informed consent 
form. Thus, 77 participants were included in the study. 
Intervention 
The intervention was structured into five to six weekly 2-hour group therapy sessions and 
guided by two course instructors. During the first implementation phase, three 5-session 
courses were conducted with 13, 16, and 11 participants. Based on the feedback provided by 
the course instructors, the course content was redistributed over six sessions. In the second 
implementation phase, four 6-session courses were conducted with 6, 8, 13, and 10 
participants. 
The treatment included therapeutic elements derived from motivational interviewing 
(Miller & Rollnick, 2002), cognitive behavioural therapy, the relapse prevention model 
(Marlatt & Donovan, 2005), and self-control practices. In addition, course instructors offered 
each participant one individual counselling session upon request and recommended NRT and 
varenicline. Furthermore, participants received a workbook and were expected to refrain from 
tobacco and cannabis use after the third session (the “quit day”). Participants who continued 
using tobacco, cannabis, or both were encouraged to make an additional attempt to quit. To 
avoid the attrition due to participant failure, the course instructors could promote reducing use 
or changing to a less harmful form of administration (e.g. orally or with a vaporiser) (Bennett, 
2008) when participants failed to quit several times. A detailed description of the intervention 
has been published elsewhere (Becker et al., 2013). 




The primary outcomes included the self-reported frequency of tobacco use (henceforth termed 
“cigarette use” because only one participant was tobacco pipe smoker, whereas all others 
smoked cigarettes), the frequency of cannabis use (including cannabis co-administered with 
tobacco; i.e. joints), and the presence of dual-abstinence from tobacco and cannabis. Baseline 
cigarette use was measured in terms of the daily amount of cigarettes smoked during a typical 
smoking day, corrected for the number of smoking days during the past month. Baseline 
cannabis use for the previous seven days was measured according to the timeline follow-back 
(TLFB) method (Hjorthøj, Hjorthøj, et al., 2012). At the EOT and 6-month follow-up, 7-day 
cigarette and cannabis use frequency were assessed using the TLFB method. Participants who 
reported that they did not use one substance were considered abstinent with regard to this 
substance. Dual-abstinence was defined as reporting neither cigarette nor cannabis use. 
Salivary cotinine was used to analytically verify self-reported dual-abstinence, with a cut-off 
value of 5-ng/ml cotinine. Participants who reported dual-abstinence but had a positive 
cotinine test were counted as non-abstinent. If this inconsistency could be explained via 
sustained NRT, then participants were counted as abstinent. Because the use of NRT was only 
assessed at EOT, this correction could not be applied for the follow-up assessment. Cannabis 
abstinence was not analytically validated because of the lack of methods of salivary delta-9-
tetrahydrocannabinol (THC) verification that are valid and applicable under the sampling and 
transport conditions (D. Lee & Huestis, 2013). Furthermore, the course instructors were 
strongly opposed to collecting urine THC samples. 
Secondary outcomes 
Nicotine dependence was measured using the Fagerstrom Test for Nicotine Dependence 
(FTND) (Heatherton, Kozlowski, Frecker, & Fagerstrom, 1991). Problematic cannabis use 
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was measured using the Cannabis Use Disorders Identification Test (CUDIT) (Adamson & 
Sellman, 2003). Problematic alcohol use was measured using the Alcohol Use Disorders 
Identification Test - Consumption (AUDIT-C) (Bush, Kivlahan, McDonell, Fihn, & Bradley, 
1998). The German short version of the Beck Depression Inventory (BDI-V) (Beck & Steer, 
1987; Schmitt, Altstötter-Gleich, Hinz, Maes, & Brähler, 2006) and the Beck Anxiety 
Inventory (BAI) (Beck, Epstein, Brown, & Steer, 1988; Margraf & Ehlers, 1995) were used to 
assess mental health. Continuous scales were used instead of cut-off values to better capture 
the variability across the range of symptoms for all variables. The CUDIT was administered at 
baseline and the 6-month follow-up; all other variables were additionally assessed at the EOT. 
Treatment process measures 
Intervention retention was defined as not missing more than one session, or missing two 
sessions but not the last session. The reasons for intervention attrition were assessed among 
the dropouts using a multiple-choice question in which more than one answer was acceptable 
(specified in Table 6); dropouts were also provided the opportunity to explicate additional 
non-listed reasons. This question was also used to determine intervention safety, defined as 
not being hospitalised due to course participation. Using semi-structured interviews conducted 
with the course instructors after course implementation, we assessed hospitalisation among 
intervention completers. 
Participant satisfaction was measured with the item, “Would you recommend the course 
to a friend in a similar situation?” with a scale ranging from 0 (“definitely no”) to 5 
(“definitely yes”) at the EOT assessment. In addition, at the follow-up participants were asked 
whether they had recommended the course to anyone. 
Baseline variables 
The demographic variables gender, age, highest educational attainment, and employment 
status were assessed at baseline. Furthermore, regular medication and lifetime use of cocaine 
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and ecstasy were measured. Readiness to quit tobacco and cannabis, respectively, was 
assessed using readiness rulers (Miller, 1999) with a scale ranging from 1 (“not at all”) to 10 
(“very much”).  
Data Analyses 
We analysed the differences between study dropouts and completers with regard to the 
baseline variables. Given the small number of dropouts, we used Mann-Whitney U tests and 
Fisher’s exact tests.  
To examine abstinence, descriptive tables were created to provide an overview of the 
number of participants abstinent from (1) cigarettes, (2) cannabis, or (3) both according to the 
self-report and the biochemical validation at the EOT and follow-up assessments. We reported 
abstinence rates based on complete case analyses (CCAs) and on an analysis in which all 
missing participants were regarded as not abstinent (MAU). 
To analyse whether the frequencies of cigarette use, cannabis use, and the secondary 
outcomes changed over time, we used generalised estimating equations (GEEs). This method 
accounts for the correlated nature of within-participant repeated-measures data. One of the 
advantages of this method is that it is consistent with intent-to-treat analyses because it 
accounts for all participants, regardless of missing values on EOT or follow-up assessments 
(Twisk, 2013). An exchangeable working correlation matrix was applied to each model, and 
measurement time (i.e. baseline, EOT, and follow-up) was entered as a predictor. To model 
variables with distributions characterised by a high proportion of zeroes (e.g. nicotine 
dependence and the frequency of cigarette and cannabis use), negative binomial models with 
a log link function were applied. A normal model with an identity link function was chosen 
for all secondary outcomes except the FTND.  
We also conducted exploratory subgroup analyses to examine whether participants who 
failed to achieve dual-abstinence but successfully quit one substance compensated for their 
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abstinence via the increased use of the remaining substance. Therefore, we calculated change 
scores for each substance by subtracting the use frequencies reported at the EOT and follow-
up, respectively, from those reported at baseline. Then, we compared these change scores 
between abstainers of only one substance and participants who continued to co-smoke using 
Mann-Whitney U tests. 
All analyses were conducted using IBM SPSS version 20.0 (IBM Inc, 2011). 
Results 
Participant Characteristics and Attrition Analysis 
At the EOT and follow-up assessments, 60 (77.9%) and 62 (80.5%) participants, respectively, 
provided at least their self-report data concerning the frequency of cigarette and cannabis use 
over the last week. Of those who indicated dual-abstinence, 10 (90.9%) and 4 (60.7%) 
participants provided cotinine samples at the EOT and follow-up, respectively.  
Table 5 shows the baseline characteristics of the sample and the comparison between 
participants who provided self-report data regarding their use frequency at the 6-month 
follow-up (n = 59) and those who did not (n = 18). Significance tests did not yield between-
group differences.  
Table 5. Baseline participant characteristics and the differences between study completers 
(followed up after 6 months; n = 59) and dropouts (n = 18) 
Characteristics Total Completers Dropouts P-value 
Demographic characteristics     
Age in years, mean (SD) 32.4 (8.2) 32.5 (7.8) 32.0 (9.7) .796 
Women, n (%)  19 (24.7) 16 (27.1) 3 (16.7) .535 
Education, n (%) a    .591 
Incomplete secondary  9 (11.8) 8 (13.8) 1 (5.6)  
Secondary 43 (56.6) 31 (53.4) 12 (66.7)  
Higher 24 (31.6) 19 (32.8) 5 (27.8)  
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Characteristics Total Completers Dropouts P-value 
Employed, n (%) b 62 (82.7) 48 (84.2) 14 (77.8) .499 
Tobacco smoking      
Cigarettes/pipes per day, mean (SD) 16.1 (9.0) 16.5 (9.6) 14.7 (6.8) .404 
Age of onset of tobacco use, mean 
years (SD) 
15.7 (2.4) 15.7 (2.6) 15.7 (1.4) .458 
FTND score, mean (SD) 4.0 (2.0) 4.0 (2.1) 4.0 (1.7) .950 
Cannabis use     
Use frequency per day, mean (SD) 3.0 (1.9) 2.9 (1.8) 3.5 (1.9) .219 
Age of onset of cannabis use, mean 
years (SD) 
16.6 (3.3) 16.8 (3.6) 15.8 (2.0) .436 
CUDIT score, mean (SD) 18.6 (7.1) 18.7 (7.6) 18.2 (5.1) .597 
Other substance use     
AUDIT-C score, mean (SD) 5.6 (2.3) 5.7 (2.1) 5.1 (2.9) .145 
Lifetime use of cocaine, n (%)  48 (62.3) 37 (62.7) 11 (61.1) 1.000 
Lifetime use of ecstasy, n (%)  45 (58.4) 35 (59.3) 10 (55.6) .797 
Readiness to quit c     
Tobacco, mean (SD) 8.3 (1.8) 8.3 (1.8) 8.3 (1.8) .865 
Cannabis, mean (SD) 7.5 (2.2) 7.5 (2.2) 7.7 (2.3) .521 
Physical/mental health      
BDI-V score, mean (SD) 35.7 (19.1) 35.7 (19.3) 35.6 (18.8) .914 
BAI score, mean (SD) 12.7 (9.5) 12.5 (9.4) 13.2 (9.8) .824 
Regular use of medication, n (%) 9 (12.0) 8 (14.0) 1 (5.6) .678 
Note. Mann-Whitney U-tests and Fisher’s exact tests; a missing values: n = 1; b missing values: n = 2; c Readiness 
to quit was measured using contemplation ladders ranging from 1 (not at all) to 10 (very much); AUDIT-C = 
Alcohol Use Disorder Identification Test - Consumption, scale ranges from 0 to 12; BAI = Beck Anxiety 
Inventory, scale ranges from 0 to 63; BDI-V = simplified Beck Depression Inventory, scale ranges from 0 to 
100; CUDIT = Cannabis Use Disorder Identification Test, scale ranges from 0 to 40; FTND = Fagerstrom Test 
for Nicotine Dependence, scale ranges from 0 to 10; SD = standard deviation. 
Treatment Participation, the Reasons for Course Disruption, and Participant Course 
Evaluations  
Of the 77 study participants, 48 (62.3%) completed the intervention. While 25 participants 
(32.5%) attended all sessions, 11 participants (15.6%) attended fewer than 50% of the 
sessions, and one participant (1.3%) attended only one session. Only seven participants used 
individual counselling; the majority of these participants spoke only briefly with the course 
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facilitators before or after the course session or during the short break, but they did not 
arrange a separate counselling session. 
Twenty-one (72.4%) of the 29 participants who discontinued the intervention provided 
reasons for course attrition (Table 6). There were no reports of any hospitalisations as a 
consequence of course participation.  
At the EOT assessment, 57 participants responded to the question regarding whether 
they would recommend the intervention to someone else. The majority of these participants 
(33, 57.9%) chose the highest value of 5 (i.e. “definitely yes”, M = 4.2, SD = 1.1). By the 
follow-up, 24 of 44 (54.5%) participants had already recommended the course to another 
person.  
Table 6. Reasons for intervention attrition, assessed among non-completers (multiple answers 
possible, n = 21) 
Reasons for intervention disruption N % of 
respondents 
I had severe problems due to the cessation (attempt). 3 14.3 
Problems with concentration 1 4.8 
Sleeping problems 3 14.3 
Depressive symptoms 2 9.5 
Distorted perceptions 1 4.8 
Problems with breathing 0 0.0 
Other 1 4.8 
I had no longer had time for the course sessions. 8 38.1 
I had already quit using tobacco before the Quit Day. 3 14.3 
I had already quit using cannabis before the Quit Day. 3 14.3 
I did not want to quit using tobacco (any more). 4 19.1 
I did not want to quit using cannabis (any more). 2 9.5 
I did not want to simultaneously quit using tobacco and cannabis 
(any more). 
5 23.8 
I felt that the intervention did not help me. 7 33.3 
Other reasons 10 47.6 
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Primary Outcomes 
A total of 32 participants (41.5%) reported either single or dual-abstinence at the EOT 
assessment. At the follow-up, 18 participants (23.4%) reported abstinence from one or both 
substances. Table 7 provides an overview of the number of abstinent participants based on the 
self-report and biochemical validation data, the response rates, and the corresponding 
abstinence rates for each time point. Of the 11 participants who indicated dual-abstinence at 
the EOT assessment, one did not provide a cotinine sample and was therefore regarded as not 
abstinent. Another two participants returned positive cotinine samples but were counted as 
abstinent because they were using nicotine patches. At the follow-up, two of the six 
participants who reported dual-abstinence did not return their cotinine sample and were 
counted as non-abstinent. 
Table 7. Seven-day abstinence rates at the end-of-treatment and 6-month follow-up 





% of CCA 
sample 
% of MAU 
sample 
End-of-treatment assessment     
Cigarette abstinence (self-report) 25 17 41.7 32.5 
Cannabis1 abstinence (self-report) 18 16 29.5 23.4 
Dual-abstinence (self-report) 11 17 18.3 14.3 
Dual-abstinence (cotinine-verified) 10 18 16.9 13.0 
6-month follow-up assessment     
Cigarette abstinence (self-report) 8 18 13.6 10.4 
Cannabis1 abstinence (self-report) 15 16 24.6 19.5 
Dual-abstinence (self-report) 6 17 7.8 10.0 
Dual-abstinence (cotinine-verified) 4 19 6.9 5.2 
Note. 1 including co-administered tobacco; CCA sample = complete cases only; MAU sample = missings treated 
as users. 
As Table 8 and Table 9 summarise, the frequencies of cigarette and cannabis use significantly 
decreased over time. 
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Table 8. Generalised estimating equation (GEE) models of use frequency and the secondary 
outcome measures over time 
Dependent variables Coefficient (IRR/b) SE 95% CI P-value 
Cigarette use frequency a 0.819 0.059 (0.730; 0.919) .001 
Cannabis use frequency a 0.699 0.073 (0.605; 0.807) < .001 
FTND a 0.687 0.082 (0.585; 0.807) < .001 
CUDIT b -3.590 0.548 (-4.663; -2.517) < .001 
AUDIT-C b -0.347 0.117 (-0.577; -0.117) .003 
BDI-V b -5.948 1.335 (-8.565; -3.332) < .001 
BAI b -3.143 0.532 (-4.186; -2.101) < .001 
Note. The predictor in every model is time; Time 1 = baseline, Time 2 = end-of-treatment assessment, Time 3 = 
6-month follow-up assessment; CUDIT was measured only at Time 1 and Time 3; a models are based on a 
negative binomial model with a log link function; b models are based on a normal model with an identity link 
function; lower values represent better outcomes for all scales. AUDIT-C = Alcohol Use Disorder Identification 
Test - Consumption; BAI = Beck Anxiety Inventory; BDI-V = simplified Beck Depression Inventory; CI = 
confidence interval; CUDIT = Cannabis Use Disorder Identification Test; FTND = Fagerstrom Test for Nicotine 
Dependence; IRR = incident rate ratio, displayed for negative binomial models; SE = standard error. 
Table 9. The means and standard deviations of the primary and secondary outcomes 
measured at baseline, the EOT assessment, and the 6-month follow-up assessment among 
complete cases 








Cigarette use frequency 54 16.23 (9.96) 5.49 (11.62) 10.76 (13.01) 
Cannabis use frequency 54 2.99 (1.96) 1.14 (1.97) 1.60 (1.76) 
FTND  38 3.76 (2.26) 1.13 (1.99) 1.92 (2.36) 
CUDIT  39 18.41 (8.17) -- 11.33 (7.63) 
AUDIT-C  40 5.20 (1.88) 4.82 (1.85) 4.70 (2.17) 
BDI-V  40 34.43 (21.19) 25.00 (19.26) 23.72 (18.58) 
BAI  40 11.92 (10.25) 7.85 (9.35) 5.84 (5.74) 
Note. Lower values represent better outcomes for all scales. AUDIT-C = Alcohol Use Disorder Identification 
Test, Consumption, scale ranges from 0 to 12; BAI = Beck Anxiety Inventory, scale ranges from 0 to 63; BDI-V 
= simplified Beck Depression Inventory, scale ranges from 0 to 100; CUDIT = Cannabis Use Disorder 
Identification Test, scale ranges from 0 to 40; EOT = end-of-treatment assessment; FTND = Fagerstrom Test for 
Nicotine Dependence, scale ranges from 0 to 10; EOT = end of treatment; SD = standard deviation. 
The results of the exploratory analyses of compensatory use after quitting only one substance 
are displayed in Table 10. According to the descriptive results, the use frequency did not 
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increase among participants who continued smoking two substances or those who quit one 
substance; rather, participants decreased their use. We did not detect group differences with 
regard to the amount of reduction. However, the respective sample sizes were low and, in the 
case of cannabis use frequency at the follow-up assessment, a significance test was omitted. 
Table 10. Mann-Whitney U tests, applied to compare the use frequency change scores 
between participants who quit one substance and those who continued using both 
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Note. EOT = end-of-treatment assessment; M = Mean; SD = standard deviation. 
Secondary Outcomes 
Table 9 shows the descriptive results of the secondary outcomes, all of which improved from 
baseline at the EOT and follow-up assessments. The GEE modelling results revealed 




The results of this study support the feasibility of the evaluated integrative group cessation 
program. First, 77 co-smokers were included in the feasibility study, and recruitment 
succeeded. Furthermore, 62.3% of participants completed the intervention. This retention rate 
is similar to the rate achieved in the pilot study that examined individual treatment of tobacco 
and cannabis co-smokers (58.3%) (Hill et al., 2013). In addition, participants’ high levels of 
satisfaction (based on their recommendation levels) illustrated feasibility. We did not find 
evidence of hospitalisation due to course participation, which suggests that the intervention is 
considerably safe. However, three participants reported experiencing severe problems due to 
their simultaneous cessation (attempts) among their reasons for discontinuing the intervention. 
This factor must be addressed when implementing the program in the future (e.g. in 
promoting the use of individual counselling, preparing participants for the possibility of 
severe problems, and motivating them to contact the course facilitators in the event they 
experience such problems). 
Ten (13.0%) and four (5.2%) participants achieved cotinine-verified dual-abstinence 
from tobacco and cannabis at the EOT and the follow-up, respectively. The self-reported 
single-abstinence rates at the EOT and follow-up assessments were higher, i.e. for cigarettes 
32.5% and 10.4%, respectively, and for cannabis 23.4% and 19.5%, respectively. The only 
other study of a combined intervention did not report abstinence rates (Hill et al., 2013).  
Furthermore, participants reduced their use of cigarettes and cannabis and improved 
regarding all secondary outcomes during the study period. These findings indicate that the 
program is potentially effective. The subgroup analyses regarding the differential changes in 
the use frequency between the quitters of one substance and those who continued co-smoking 
indicated that quitting one substance does not lead to a compensatory increase in the 
remaining substance when both substances are targeted in an integrative treatment, such as the 
present one. A substitution effect has been a major concern with regard to implementing 
PAPER 2  
98 
tobacco smoking interventions within other substance abuse treatments (S. M. Hall & 
Prochaska, 2009). 
One limitation of this study is that the study attrition limits the generalisability of the 
results. However, the dropout analysis revealed that participants who provided follow-up data 
did not differ significantly from dropouts with regard to their baseline characteristics. Another 
limitation is the lack of an analytical validation for cannabis abstinence. Although salivary 
cotinine samples are an appropriate measure to validate tobacco abstinence, a reliable method 
for detection of THC and/or its metabolite THC-carbonic acid and the interpretation of 
corresponding analytical findings, respectively, is still lacking (D. Lee & Huestis, 2013). 
Nevertheless, the TLFB assisted self-report is a valid measure of cannabis use frequency 
(Hjorthøj, Fohlmann, Larsen, Arendt, & Nordentoft, 2012; Hjorthøj, Hjorthøj, et al., 2012). 
An additional limitation of this study is that the presence of NRT, which might explain the 
inconsistencies between self-reported and cotinine-validated abstinences, was not assessed at 
the 6-month follow-up assessment.  
Randomised trials must be conducted to evaluate the efficacy of integrative 
interventions compared with single interventions among co-smokers. Moreover, future studies 
should implement feasible blood or urine verification methods for cannabis abstinence and 
evaluate alternatives to a designated quit date for all participants and both substances. For 
instance, staggered quit dates for tobacco and cannabis might be useful because evidence 
suggests that recent cigarette abstinence does not decrease the likelihood of a cannabis relapse 
(Haney et al., 2013). Furthermore, a clinical comparison study found that withdrawal was 
more severe during simultaneous cessation than during single cessation; however, this 
difference was only for a short duration, and substantial inter-individual variability was 
reported (Vandrey et al., 2008). Finally, analysing how treatment goals other than dual-
abstinence affect the treatment outcomes might be helpful in improving treatment success. For 
example, a tobacco-abstinence goal combined with a cannabis-use-moderation goal might be 
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an alternative because a study that evaluated a guided self-change treatment found that most 
cannabis users chose to reduce their cannabis use rather than to abstain (Sobell et al., 2006). 
However, a cannabis abstinence goal combined with a reduced tobacco use goal is also a 
possibility because tobacco cessation might be a barrier to seeking treatment (Budney et al., 
2007): Cannabis users seem to be less likely to select an abstinence goal for tobacco use 
compared with tobacco-only smokers (Ramo et al., 2013). 
The present study demonstrated the feasibility of an integrative group cessation program 
that targeted co-smokers of tobacco and cannabis. Clinicians treating participants with 





PAPER 3. Effectiveness of Different Web-Based Interventions to Prepare 
Co-Smokers of Tobacco and Cannabis for Double-Cessation: A Three-Arm 
Randomised Trial 
Becker, J., Haug, S., Sullivan, R., and Schaub, M. P. 
Abstract 
Background. The relationship between tobacco and cannabis use is strong. When co-smokers 
try to quit only one substance this relationship often leads to a substitution effect, i.e. an 
increased use of the remaining substance. Stopping the use of both substances simultaneously 
is therefore a reasonable strategy, but co-smokers report rarely to be ready for simultaneous 
cessation. Thus, the question of how co-smokers can be motivated for a simultaneous 
cessation attempt has arisen. In order to reach as many co-smokers as possible, we developed 
brief, web-based interventions which aimed at enhancing the readiness to simultaneously quit 
tobacco and cannabis use. 
Objective. To analyse three different web-based interventions regarding their efficacy in 
enhancing co-smokers’ readiness to stop tobacco and cannabis use simultaneously. 
Methods. Within a randomized trial, three brief, web-based and fully automated interventions 
were compared. The first intervention combined assessment of cigarette dependence and 
problematic cannabis use with personalised, normative feedback. The second intervention was 
based on principles of motivational interviewing. As active psycho-educative control group, 
the third intervention merely provided information on tobacco, cannabis, and the co-use of the 
two substances. The readiness to quit tobacco and cannabis simultaneously was measured 
before and after the intervention, as well as eight weeks later. Secondary outcomes were 
cigarette and cannabis use frequency, measured at baseline and after eight weeks. A total of 
2467 website-users were assessed for eligibility of tobacco and cannabis co-use and 325 
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participants were randomized and analysed. 
Results. For the post-intervention assessment, generalised estimating equations (GEEs) 
revealed a significant increase in the readiness to quit tobacco and cannabis in the total 
sample, B = 0.33, 95% CI [0.10, 0.56], p = .006. However, this effect was not significant for 
the comparison between baseline and follow-up assessment (p = .69). Furthermore, no 
differential effects between the interventions were found. Moreover, there were no significant 
intervention or time effects for the frequency of tobacco or cannabis use. 
Conclusions. In the new field of dual interventions for co-smokers of tobacco and cannabis, 
web-based interventions can increase short-term readiness to quit tobacco and cannabis 
simultaneously. The studied personalized techniques were not more effective than 
psychoeducation. The analysed brief interventions did not change frequency of tobacco and 
cannabis use.  
Introduction  
The Relationship between Tobacco and Cannabis Use 
While smoking tobacco is the leading global cause of preventable death (World Health 
Organisation, 2011), cannabis is the most widely used illicit drug (UNODC, 2012) and is 
associated with a range of physical and mental health problems (Caldeira et al., 2012; W. Hall 
& Degenhardt, 2009). Both substances are often used together, as the majority of cannabis 
users also smoke cigarettes. In a study in the United States, 74% of the marijuana users 
smoked cigarettes, compared to 29% of the nonusers (Richter et al., 2005). Furthermore, 
cannabis use is reportedly more common among cigarette smokers than it is among non-
smokers. In the National Survey on Drug Use and Health (NSDUH) in the United States, the 
30-day prevalence of cannabis use was 35% among tobacco smokers and only 9% among 
non-smokers (Substance Abuse and Mental Health Services Administration, 2013). In a 
similar survey in Switzerland, cannabis use in the previous 12 months was reported by 28% of 
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the adolescents who smoked tobacco daily compared to 9% and 2% of the adolescents who 
were ex- and never-smokers, respectively (Radtke et al., 2011). 
The mechanisms that link the use of both substances are assumed to go beyond the 
mechanisms that explain the co-use of drugs in general (Agrawal et al., 2012). For instance, 
both substances are usually smoked (have a shared route of administration) and are often used 
simultaneously (co-administration), i.e. tobacco is added to cannabis joints (‘mulling’) or is 
smoked directly after cannabis (‘chasing’) (Agrawal et al., 2012; Peters et al., 2012). In 
Switzerland, 97% of cannabis users smoke cannabis joints mixed with tobacco (Baggio et al., 
2013).  
In the context of cessation, the relationship between both substances is often 
problematic. For instance, tobacco smokers who also consume cannabis seem to make fewer 
efforts to quit tobacco (Ford et al., 2002) and tend to be less successful in quitting tobacco 
compared to tobacco-only smokers (Abrantes et al., 2009). Furthermore, the cessation of one 
substance is frequently accompanied by an increased use of the other (Akré et al., 2010; Amos 
et al., 2004; Copersino et al., 2006), and cessation programs that exclusively address tobacco 
appear to be less effective for co-smokers of cannabis (Gourlay et al., 1994; Moore & 
Budney, 2001).  
Interventions for Tobacco and Cannabis Use 
Despite these findings, interventions have typically targeted tobacco or cannabis use alone 
and have rarely addressed both substances simultaneously. One explanation for the separate 
treatments may be that in many industrialised countries, the treatment of cannabis dependence 
is provided by psychiatrists, while interventions for tobacco smokers are part of a more 
general public health system (S. M. Hall & Prochaska, 2009; J. J. Prochaska, 2010). However, 
the body of literature on the relationship between tobacco and cannabis use is growing, and 
authors of recent reviews perceive a demand for double interventions targeting tobacco and 
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cannabis simultaneously (Agrawal et al., 2012; Peters et al., 2012; Ramo et al., 2012). In line 
with this notion, a preliminary study of the development of such a program has indeed 
revealed this demand (Becker et al., 2013). The experts and the co-smokers who participated 
in the preliminary study considered a dual cessation intervention as feasible.  
However, the participants also expected only modest readiness to simultaneously quit 
tobacco and cannabis use, as half of the surveyed co-smokers were unaware of the association 
between tobacco and cannabis use (Becker et al., 2013). Due to this finding, we developed 
three brief online interventions to enhance co-smokers’ awareness of the relationship between 
the substances as well as their readiness to simultaneously quit each substance. The purpose 
of the current study was to evaluate these online interventions and examine how co-smokers’ 
readiness to simultaneously quit tobacco and cannabis can be augmented. Motivational 
constructs such as the stages of change and the readiness to quit have been shown to predict 
the subsequent engagement in interventions (Biener & Abrams, 1991; Hogue, Dauber, & 
Morgenstern, 2010) and abstinence (Velicer, Redding, Sun, & Prochaska, 2007). 
Because of its easy access and ubiquitous presence, the Internet arose as a potentially 
effective medium to reach a large number of co-smokers who might be unaware of the 
relationship between their tobacco and cannabis use. Personalised, normative feedback is one 
motivational technique that can be applied to web-based interventions for substance use. 
Based on the social norms approach (Perkins, 2003), such interventions typically include self-
assessment sections and feedback sections in which the participants’ behaviour is compared to 
a reference sample. The overestimation of substance use by others is common and is 
positively associated with one’s own use (Bertholet et al., 2013). Web-based social norm 
interventions use this association and aim to correct the participants’ erroneous perceptions. 
Mostly studied among college students and targeting alcohol use, web-based norms 




A further established technique for building motivation is motivational interviewing 
(MI), which uses a client-centred, directive counselling style to explore and reduce 
ambivalence and increase the intrinsic motivation for change (Miller & Rollnick, 2002). Brief 
face-to-face interventions based on MI have been found to be effective in reducing cannabis 
use (Stephens et al., 2000) and may assist in smoking cessation (Lai, Cahill, Qin, & Tang, 
2010). MI in web-based interventions is usually applied as a chat-intervention but is not fully 
automated. However, the first promising results of fully automated MI have recently been 
revealed by a computer-based intervention targeting perinatal drug use (Ondersma, Chase, 
Svikis, & Schuster, 2005). 
For this study, we developed three web-based interventions that apply the above-
mentioned techniques, i.e. normative feedback and MI. For an active control group, we used 
web-based psychoeducation. In addition, to maintain the low threshold for Internet access and 
keep the study dropout rate as low as possible, the interventions were designed as brief single-
session interventions.  
Aims of the Study and Hypotheses 
The main aim of this study was to evaluate three web-based interventions regarding their 
effectiveness in enhancing co-smokers’ readiness to quit both tobacco and cannabis 
simultaneously. Our first hypothesis (H1) was that the tested interventions would be effective 
in enhancing readiness to simultaneously quit tobacco and cannabis use. Thus, we assumed a 
significant within-subjects effect for assessment time. Because particular interactive 
interventions that were tailored to individuals have shown promising effects in aiding 
smoking cessation (Civljak et al., 2013), our second hypothesis (H2) was that interactive and 
tailored interventions, i.e. an intervention based on MI and an intervention providing 
normative feedback, would more effectively enhance co-smokers’ readiness to quit tobacco 
and cannabis use simultaneously compared to mere psychoeducation. Because MI has shown 
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promising effects as a motivational enhancement strategy for cannabis users (D’Amico, 
Miles, Stern, & Meredith, 2008), we additionally hypothesised that this intervention would 
outperform the effectiveness of the normative feedback intervention (H3).  
Furthermore, this study aimed to evaluate the three interventions as they pertained to 
secondary outcome variables, i.e. the frequencies of tobacco and cannabis use. We had the 
same hypotheses for these outcomes as those explained above. 
Methods  
Study Design and Setting 
To test our hypotheses, we conducted a three-armed randomised trial (ISRCTN56326375) 
with pre-, post- and 8-week follow-up assessments. The three single-session interventions 
were web-based and fully automated. The baseline assessment (t0) was conducted at the 
beginning of the intervention session, and the post-intervention assessment (t1) immediately 
followed the intervention. After eight weeks, the subjects were re-assessed (follow-up, t2) by 
phone or online. However, our primary focus was set on the immediate post-intervention 
assessment because our primary outcome, the readiness to simultaneously quit tobacco and 
cannabis, would not be applicable to those participants who stopped smoking tobacco or 
cannabis after the intervention at t2. 
The interventions were integrated within a German-language website (www.i-cut.ch), 
which, besides the interventions, contained information about an integrative group cessation 
course for co-smokers of tobacco and cannabis. This cessation course is evaluated in a 
separate study (ISRCTN15248397).  
Participants could enter the current study in one of two ways. First, they could enter it 
directly from the start page of the website, where participants could choose between “getting 
more information about the course” and “learning more about my use of tobacco and 
cannabis”. They were then directed to the course information pages or to the intervention 
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session, respectively. We chose the cover term “learning more about my use of tobacco and 
cannabis” for the intervention session to attract co-smokers who were not seeking treatment. 
The second way to enter the study was to switch there from the course information pages by 
clicking a teaser that was displayed on the right side of each information page. It was also 
labelled “learning more about my use of tobacco and cannabis” (Figure 2). Conversely, 
participants could switch from the intervention session to the course information pages by 
clicking a hyperlink (“register now for the tobacco and cannabis cessation course”). This 
hyperlink was present on every page of the intervention, and the participants who clicked on it 
were directed to the course information pages and dropped out of the present study. Figure 3 
shows a sample page of the intervention and the hyperlink. 
 
 
Figure 2. Screenshot of the teaser (red square) for the web-based intervention as it was 





Figure 3. Screenshot of the intervention (intervention arm: motivational interviewing) and the 
hyperlink (red square) that directed participants to the web pages with information about the 
smoking cessation course. 
Eligibility and Recruitment 
The inclusion criteria for study participation included any tobacco use during the past four 
weeks and any cannabis use during the past six months. As implicit inclusion criteria, 
participants had to speak German and be computer literate. There were no age restrictions or 
other exclusion criteria.  
Recruitment for the present study ran parallel to recruitment for a feasibility study of the 
above-mentioned smoking cessation course for co-smokers of tobacco and cannabis. This was 
conducted in Zurich and a neighbouring city. The recruitment strategy has been described in 
the publication on the course development (Becker et al., 2013). Briefly, recruitment was 
carried out online and offline. First, a press release about the course was issued, which 
resulted in several reports in local newspapers and on radio and TV stations. Furthermore, 
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brochures and leaflets were sent to counselling centres for addiction prevention and treatment, 
psychiatrists, and health (care) centres in the canton of Zurich and in the bordering cantons. 
Additionally, two social media platforms and a teaser in the online edition of a popular free 
newspaper were used for recruitment. All of these referred to the start page of the website for 
more information. 
To maximise the response rates, study participants were also offered the opportunity to 
participate in a lottery for three vouchers valued at 300, 200, or 100 Swiss Francs after they 
completed the first session, including the second measurement. Additionally, a second lottery 
for the same values served as an incentive to participate in the follow-up measurement. The 
data were collected from January to December 2012. 
Procedure 
 
Figure 4. Study procedure. 
Figure 4 illustrates the study procedure in detail. The initial questions presented to potential 
participants were used to check the inclusion criteria. If the users met these criteria, they were 
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informed about the opportunity to participate in a study aiming to improve the website’s 
information offerings. Those who did not fulfil the inclusion criteria or did not provide 
informed consent were excluded from the study and were referred to a webpage that 
contained information on tobacco and cannabis use, which was also provided in the psycho-
educational intervention (see below).  
Once the baseline measurement (t0) was completed, participants were randomly 
assigned to one of three possible interventions. After finishing the intervention, participants 
were reassessed (post-intervention, t1) and informed about the 8-week follow-up assessment 
(t2). To keep the threshold for entering the study as low as possible, the information about the 
follow-up assessment was only provided at this point. This was done because the main aim of 
the present study was to enhance the readiness to simultaneously quit tobacco and cannabis 
between t0 and t1. Participants who provided informed consent for the follow-up assessment 
could indicate whether they wanted to answer the follow-up questionnaire online or over the 
phone. At the end of the session, participants were referred to the webpage of the group 
cessation program if they were interested.  
For the follow-up assessment, participants were contacted after eight weeks via their 
chosen mode (i.e. via email including a link to the online questionnaire or via telephone). 
Those who preferred to answer the questionnaire online received an email reminder after 
about two weeks if they had not yet completed the online questionnaire. Those who chose the 
telephone questionnaire were contacted up to ten times.  
Interventions 
General Information and Technological Background 
Participation in the interventions was free, and access was open for every eligible participant. 
The delivery of interventions was fully automated. The open source software LimeSurvey 
(Version 1.91) was used to program the survey and the interventions. 
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As described below, the interventions varied in the extent to which they were interactive 
with the participants. Additionally, the interventions differed in the way in which each was 
tailored to the responses that the participants had given during the baseline assessment and 
during the interventions themselves.  
Intervention 1: Normative feedback (NF) 
The first intervention contained a combination of self-assessment and personalised normative 
feedback (NF). It consisted of three sections, including one each for tobacco use, cannabis 
use, and co-smoking. In the first and second sections, participants began by completing a 
questionnaire (the Fagerstrom Test of Nicotine Dependence, FTND (Bleich, Havemann-
Reinecke, & Kornhuber, 2002; Heatherton et al., 1991), and the Cannabis Use Disorder 
Identification Test, CUDIT (Annaheim, Rehm, & Gmel, 2008), respectively). Participants 
received feedback following each questionnaire. Feedback was individually tailored to 
participants using an algorithm based on the results from the FTND, the CUDIT, and the 
baseline data. Based on the social norms approach, each participant’s reported frequency of 
smoking was presented in relation to the normative data from Swiss community samples. 
Afterwards, participants received feedback about their questionnaire scores and whether their 
responses met criteria for dependency (FTND) and/or problematic use (CUDIT), respectively. 
Explanations of “cigarette dependence” and “problematic cannabis use” were also given. 
Each substance-specific section concluded with brief recommendations for cessation or 
moderation of use. In addition, at the end of the intervention, information was provided that 
simultaneously accounted for the participant’s use patterns of tobacco and cannabis. 
Participants who regularly smoked both tobacco and cannabis were informed about the group 
cessation course and referred to the end of the post-intervention assessment for further 
information. Participants who used either just one of the substances or both less regularly 




Table 11. Examples of feedback provided during the normative feedback intervention to a 
participant who smoked more than five cigarettes per day and used cannabis less than once 
per week 
Intervention step Example 
Feedback on tobacco use 
frequency 
You indicated smoking an average of 12 cigarettes per day. 
Among Swiss males, 70% do not smoke at all. Only 
approximately 10% smoke more than you. 
Feedback on cigarette 
dependence 
Your nicotine dependence is classified as high.  
Your result means that quitting may be more difficult for you 
compared to people with low dependence. Presumably, you 
will experience withdrawal symptoms. Nevertheless, these 
symptoms will weaken soon, and there are helpful aids 
against them. For instance, nicotine replacement therapy is 
very effective. However, quitting smoking requires more than 
just getting through the withdrawal symptoms. For example, 
you should develop individual strategies which help you cope 
with risk situations in which the temptation of smoking a 
cigarette is high. Professional support (e.g. a smoking 
cessation course) can be very helpful in developing such 
strategies.  
Feedback on cannabis use 
frequency  
During the past four weeks, you used cannabis two or three 
times. A survey revealed that 89% of Swiss adolescents and 
young adults do not use cannabis at all. Only 4% use it more 
often than you.  
Combined feedback  Of course, it is not easy to quit both substances 
simultaneously for good, especially after having smoked 
cigarettes on a regular basis. You can ask for support at 
[name of a centre for addiction counselling and treatment] 
and mention that you also smoke joints occasionally. 
 
Intervention 2: Motivational interviewing (MI) 
The second intervention was based on the principles of motivational interviewing (MI). It was 
highly interactive and tailored to the participant, and it used a selection of MI techniques that 
could be adapted to a web-based intervention, such as open-ended questions, affirmative 
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feedback, and periodic summaries. The aim of this intervention was to promote participants’ 
self-reflective thinking about their own smoking behaviour and intentions to change it and to 
enhance their self-confidence in the ability to change. This was done in different tasks, such 
as decisional balance tasks, in which participants wrote down personal pros and cons of 
stopping tobacco use, cannabis use, or both simultaneously (Figure 3). Participants were also 
asked to write down what advice they would give to a co-smoking friend and to indicate their 
confidence in successfully stopping tobacco, cannabis, or both simultaneously on a 
confidence ruler. Participants received feedback, including a brief summary of their indicated 
change in self-confidence and a brief informational text about the simultaneous cessation of 
tobacco and cannabis use. To further enhance their self-confidence, participants were asked to 
list any behaviour that they had successfully changed in the past and to write down the names 
of persons in their network who could provide some level of social support during an attempt 
to quit smoking. Participants who, at baseline, had low levels of motivation to quit smoking 
and cannabis simultaneously received a further task. 
Intervention 3: Psychoeducation (PE) 
The third intervention was the active control group and provided psycho-educational 
information (PE) about tobacco and cannabis use. The information was thematically 
subdivided into smaller subsections. Participants had to read the sections in sequential order. 
Several terms and concepts that some readers may not know (e.g. “carbon monoxide”) were 
explained in a small text box that appeared when mousing over the word of interest (Figure 
5). The PE intervention started with an explanation of the association between the two 
substances with regard to the initiation and cessation of their use, their linking mechanisms, 
and the potential health consequences of their co-use. The next chapter contained information 
about the short- and long-term consequences of tobacco use, tobacco dependence, and the 
cessation of tobacco use and was followed by an analogous chapter on cannabis. The final 
chapter provided information about changing smoking behaviour and addressed smoking 
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reduction versus abstinence, the simultaneous cessation of tobacco and cannabis use, and 
support during the cessation process. At this point, the group cessation program was 
mentioned and participants were referred to the end of the post-intervention assessment to 
receive further information.  
 
 
Figure 5. Screenshot of a section in the psycho-educational intervention. 
Outcome Measures 
The primary outcome measure was participants’ readiness to quit the use of tobacco and 
cannabis simultaneously. Readiness was measured at all three time points by the question “To 
what extent are you ready to quit tobacco and cannabis simultaneously?” Participants 
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indicated their readiness on a ruler ranging from 1 (“not at all”) to 10 (“very much”). The item 
was designed based on the contemplation ladder (Biener & Abrams, 1991), which is 
especially suited to measure early stages of readiness. In addition, a comparison of the 
readiness ruler to other measures of motivation to change revealed its good concurrent and 
predictive validity and its superior clinical utility when its brevity and ease of administration 
are considered (Maisto et al., 2011). 
Secondary outcomes included the self-reported frequency of tobacco and cannabis use 
at baseline (t0) and at the 8-week follow-up (t2). The frequency of tobacco use was defined as 
the daily amount of cigarettes smoked during a typical smoking day, corrected for the number 
of smoking days during the past month. The frequency of cannabis use in the past week was 
assessed using 7-day timeline follow-back question (Norberg, Mackenzie, & Copeland, 
2012).  
Baseline Measures 
At baseline, we assessed key demographic variables, i.e. age, sex, highest educational 
attainment, and nation of residence. Furthermore, we measured participants’ smoking history, 
i.e. age of onset of tobacco and cannabis use, and the number of prior attempts to quit tobacco 
use, cannabis use, or both simultaneously. 
Statistical Analysis 
According to the intention-to-treat principle, all participants who provided informed consent 
and communicated their intention to provide serious answers to the questionnaire were 
included in the analyses. Using the Amelia II multiple imputation package of the R software 
environment for statistical computing, Version 2.15.3 (R Core Team, 2013), we imputed 20 
datasets. In a simulation study using data from an online self-help program for problem 
drinkers, Amelia II outperformed other methods of multiple imputation (Blankers, Koeter, & 
Schippers, 2010). Hypotheses tests were performed using each data set separately and were 
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pooled afterwards (intention-to-treat analysis). To determine the robustness of our results to 
the analytic strategy, we also performed complete case analyses considering only participants 
who provided data at all three assessments. 
Trial arm differences in baseline measurements were tested using analysis of variance 
(ANOVA) and the Kruskal-Wallis-test for continuous variables and chi-square tests for 
categorical variables, depending on each variable’s parametric properties. The differential loss 
to the post-intervention assessment and the follow-up assessment was analysed using chi-
square tests. 
To analyse the primary and secondary outcome variables, we used generalised 
estimating equations (GEE) that consider the correlated nature of repeated measures. In the 
GEE models used to test H1, the only predictor was measurement time. The GEE models used 
to test differential effects of the interventions (H2 und H3) considered five variables: 
measurement time, intervention type, interaction of time and intervention type, gender, and 
baseline readiness to quit cannabis. Measurement time was entered as a dummy-coded 
categorical variable, with the baseline measurement being the reference category. In the GEEs 
that modelled the secondary outcomes, time was binary because the frequency of use was 
measured only at t0 and t1. Interaction effects examined whether the intervention type had a 
differential effect on the changes in the outcome variable over time in the two compared 
groups, thus answering H2 and H3. Gender and baseline readiness to quit cannabis use were 
included as control variables because they differed between the two groups at baseline.  
To directly test the postulated differential effects by intervention group, the 
interventions were grouped by hypothesis and analysed in two separate models. One model 
contrasted the PE intervention as a reference category with the combination of MI and NF 
(H2), whereas the second model contrasted the two interactive, personalised intervention 
types, NF and MI, with each other (H3).  
All GEE models were based on an unstructured working correlation matrix. For the 
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models of readiness to quit, a normal model with an identity link function was chosen. In the 
models of frequency of tobacco and cannabis use, we used a negative binomial model with a 
log link function. 
The alpha level was set at α = .05, and the analyses were performed using R (R Core 
Team, 2013), Stata 12.1 SE (StataCorp., 2011), and IBM SPSS Statistics Version 20 (IBM 
Inc, 2011). 
The power calculation was based on the outcome of primary interest, the readiness to 
simultaneously cease tobacco and cannabis use, as measured directly after the intervention 
(t1). For a 3 x 2 repeated measurements design, a total sample size of N = 246 was required to 
detect small effects with a 2-sided type I error rate α = .05 and a power of 80% (Bortz & 
Döring, 2006, p. 633).  
Ethical Approval and Study Registration 
The study was designed in accordance with the Helsinki declaration and was approved by the 
ethics committee of the Canton of Zurich, Switzerland (approval number: KEK-StV-Nr. 
23/11, June 27, 2011, and amendment for the internet-based intervention, November 11, 





Baseline Characteristics, Response Analysis, and Intervention Duration 
 
Figure 6. Participant flow chart. 
As shown in Figure 6, of the 2476 users who were assessed for eligibility, 1468 met inclusion 
criteria. Of those, 325 (22.1%) provided informed consent, completed the baseline 
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assessment, and could therefore be randomised into one of the intervention groups. Of them, 
261 (80.3%) participants completed the intervention, and 83 (25.5%) participated in the 
follow-up assessment.  
Table 12 compares the baseline variables across the intervention groups. Except for the 
relatively high percentage of women (30.3% vs. 14.9% in the NF and 17.6% in the MI 
interventions) and the higher readiness to quit cannabis use in the PE intervention, no baseline 
variables differed significantly across the three groups. 
Table 12. Trial arm differences in baseline variables 
Baseline Variable PE NF MI Significance 
    F (df) / χ2 (df) p 
N 109 114 102   
Females, n (%)  33 (30.3) 17 (14.9) 18 (17.6) 8.91 (2) .01 
Age in years, M (SD) 30.5 (9.5) 29.2 (9.6) 29.6 (9.5) 1.22 (2) .54 
Tobacco use frequency (cigarettes 
per day), M (SD) 
12.5 (7.7) 12.0 (8.2) 13.6 (8.6) 2.16 (2) .34 
Cannabis use frequency (times per 
day), M (SD) 
2.5 (1.9) 2.3 (2.3) 2.3 (2.2) 3.54 (2) .17 
Age of tobacco use onset, M (SD) 16.0 (3.2) 15.8 (2.9) 16.0 (2.7) 0.17 (2,322) .84 
Age of cannabis use onset, M (SD) 17.1 (4.4) 16.3 (3.4) 16.5 (3.1) 1.09 (2,322) .34 
Prior simultaneous cessation 
attempt, n (%) 
32 (29.4) 38 (33.6) 32 (31.4) 0.47 (2) .79 
Readiness to quit tobacco, M (SD) 7.2 (2.4) 7.0 (2.7) 7.5 (2.4) 1.42 (2) .49 
Readiness to quit cannabis, M (SD) 5.8 (3.0) 4.8 (3.3) 5.1 (2.9) 6.03 (2) .049 
Readiness to quit tobacco and 
cannabis simultaneously, M (SD) 
5.2 (2.8) 4.7 (3.0) 5.0 (2.9) 2.40 (2) .30 
Note. PE=psychoeducation, NF=normative feedback, MI=motivational interviewing. 
During the intervention and the post-intervention measurement (t1), 85 (26.2%) participants 
dropped out, and 98 (30.2%) did not provide informed consent for the follow-up assessment. 
A total of 85 (26.2%) participants provided follow-up data. The drop-out analysis revealed no 
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trial arm differences in the percentage of participants who did not participate in the follow-up 
assessment, χ22 = 5.20, p = .07. However, the groups significantly differed with regard to their 
participation in the post-intervention assessment, χ22 = 23.23, p < .001. Specifically, the 
highest participation rate in the follow-up was achieved in the NF intervention (94.7%) 
compared to participants in the PE (73.4%) and MI interventions (71.6%). 
Regarding their duration, the interventions differed significantly. Overall, participants 
remained in the intervention sessions for an average of 25.5 minutes (SD = 33.0), including 
the baseline and post-intervention assessments. While the participants in the NF condition 
finished the session after M = 17.0 minutes (SD = 9.1) on average, participants in the PE 
(M = 28.4, SD = 38.4) and the MI (M = 28.9, SD = 41.6) interventions stayed significantly 
longer, F(2, 322)  = 4.7, p = .01. 
Effects of the Intervention on Readiness to Simultaneously Quit Tobacco and Cannabis 
Use  
As shown in Figure 7, the readiness to quit tobacco and cannabis use simultaneously slightly 
increased in all interventions between t0 and t1 and decreased thereafter. The GEE analysis 
used to test time effects in the total sample (H1) revealed that readiness to simultaneously quit 
was significantly higher at post-intervention compared to baseline, B = 0.33, Standard Error 
SE = 0.12, 95% CI [0.10, 0.56], p = .006. At the follow-up assessment; however, the readiness 
to simultaneously quit was no longer significantly higher compared to the baseline level, B = -




Figure 7. Course of readiness to simultaneously quit tobacco and cannabis use over time. 
PE = psychoeducation, NF = normative feedback, MI = motivational interviewing, t0 = 
baseline, t1 = post-intervention, t2 = 8-week follow-up. 
Table 13 displays the results of the GEE models, testing the two hypotheses concerning the 
differential change in readiness to quit tobacco and cannabis use simultaneously. Regarding 
H2, there was a significant main effect for time in examining the change in readiness to quit 
simultaneously from baseline (t0) to the post-intervention (t1) assessment. However, this 
effect was not maintained at follow-up (t2). Furthermore, neither the intervention effect nor 
the time*intervention interaction was significant. As the analysis of H3 revealed, there were 
no significant time effects for readiness to quit simultaneously when only MI and NF were 
included in the model. In both models, the control variable baseline readiness to stop cannabis 
use at baseline was a significant predictor of readiness to stop both tobacco and cannabis use 
simultaneously. 
The complete case analyses replicated these findings. The first model using the total 
sample revealed a significant time effect at t1, B = 0.31, SE = 0.11, 95% CI [0.37, 1.54], 
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the post-intervention with the baseline assessment was significant, B = 0.95, SE = 0.18, 95% 
CI [0.37, 1.54], p = .001). In the model used to test H3, there was no significant effect, except 
the control variable baseline readiness to quit cannabis use. 
 
Table 13. Results from linear generalised estimating equation (GEE) models examining 




SE 95% CI p 
lower upper 
H2 Intercept 1.83 0.38 1.07 2.58 <.001 
Groups NF & MI a 0.07 0.25 -0.43 0.56 .80 
Time t2 b -0.06 0.42 -0.89 0.78 .90 
Time t1 b 0.59 0.19 0.22 0.96 .002 
Time t2 b × Groups NF & MI a -0.12 0.40 -0.90 0.66 .76 
Time t1 b × Groups NF & MI a -0.40 0.22 -0.83 0.03 .07 
Baseline readiness to stop 
cannabis use 
0.57 0.04 0.48 0.65 <.001 
Female gender c 0.17 0.29 -0.40 0.74 .56 
H3 Intercept 1.59 0.45 0.70 2.47 <.001 
Group MI d 0.20 0.29 -0.37 0.76 .50 
Time 2 b -0.03 0.42 -0.88 0.81 .94 
Time 1 b 0.22 0.14 -0.06 0.50 .13 
Time 2 b × Group MI d -0.30 0.45 -1.18 0.58 .50 
Time 1 b × Group MI d -0.06 0.28 -0.60 0.48 .83 
Baseline readiness to stop 
cannabis use 
0.59 0.05 0.49 0.69 <.001 
Female gender c 0.29 0.41 -0.50 1.09 0.47 
Note. GEE models with 20 imputed data sets. SE = standard error; MI = motivational interviewing intervention; 
NF = normative feedback intervention. a reference: PE (psychoeducation); b reference: t0 (baseline); c reference: 
male gender; d reference: NF. 
Effects of the Intervention on Secondary Outcomes  
Descriptive statistics for the frequency of tobacco and cannabis use showed only a weak 
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decrease in frequency between the baseline and follow-up assessments (Table 14). The GEE 
model that analysed H1 did not reveal a significant time effect for the frequency of either 
tobacco use, Incidence Risk Ratio IRR = -0.04, SE = 0.09, 95% CI [-0.23, 0.15], p = .70, or 
cannabis use, IRR = -0.05, SE = 0.12, 95% CI [-0.29, 0.20], p = .70.  
None of the analyses of differential changes in the frequency of either tobacco or 
cannabis use revealed a significant time effect, intervention effect or time*intervention 
interaction. 
The complete case analyses predominantly replicated these findings, revealing no 
significant time, group, or time*group interaction effects in the GEE models of tobacco or 
cannabis use frequency. One exception was a significant time effect for the frequency of 
tobacco use among the total sample (H1), IRR = 0.89, SE = 0.04, 95% CI [0.81, 0.98], 
p = .02). 
Table 14. Means and standard deviations of the frequency of tobacco and cannabis use at 
baseline and 8-week follow-up 
Outcome variable  PE NF MI Total 
  M (SD) M (SD) M (SD) M (SD) 
Tobacco use frequency 
(cigarettes per day) 
t0 12.5 (2.4) 12.0 (2.5) 13.6 (2.5) 12.7 (2.5) 
t2 12.5 (2.5) 11.0 (2.5) 13.4 (2.7) 12.3 (2.6) 
Cannabis use frequency 
(times per week) 
t0 2.5 (1.4) 2.3 (1.4) 2.3 (1.4) 2.3 (1.4) 
t2 2.4 (1.4) 2.2 (1.4) 2.2 (1.4) 2.2 (1.4) 
Note. Descriptive statistics were calculated using the 20 imputed data sets. PE=psychoeducation, NF=normative 
feedback, MI=motivational interviewing, t0=baseline assessment, t2=8-week follow-up assessment. 
Discussion  
Principal Results 
This study evaluated three brief, fully automated web-based interventions which aimed to 
enhance co-smokers’ readiness to simultaneously quit their tobacco and cannabis use. 
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Regarding one’s readiness to simultaneously quit using tobacco and cannabis, we assumed 
that all participants would have an increased level of readiness after the intervention 
compared to the baseline assessment (H1). Furthermore, we hypothesised that more 
interactive and individually tailored interventions would be more effective compared to mere 
information provision (psychoeducation) (H2). Additionally, we tested the hypothesis that a 
web-based intervention that applies principles derived from MI would be even more effective 
than an intervention that provides tailored, normative feedback (H3). The hypotheses 
regarding these secondary outcomes as well as tobacco and cannabis use frequency were 
analogous. 
Regarding the readiness to simultaneously quit tobacco and cannabis use, the results 
supported our first hypothesis, That is, in the total sample, the readiness to simultaneously 
quit was significantly elevated at the post-intervention assessment relative to baseline. This 
effect had disappeared by the 8-week follow-up assessment. The two hypotheses that assumed 
differential intervention effects were thus not supported. With regard to the frequency of 
tobacco and cannabis use, our analyses did not reveal time or intervention effects.  
Strengths and Limitations 
Among the strengths of this study is that it is the first study of web-based interventions that 
target co-smokers of tobacco and cannabis. Furthermore, the interventions are fully automated 
and therefore require no personnel beyond their initial development.  
Among the limitations of this study was its high attrition rate regarding participation at 
the follow-up assessment. However, high attrition rates are common in eHealth studies and 
brief interventions (Eysenbach, 2005). We addressed this by using multiple imputation 
methods and performing traditional complete case analyses. Furthermore, our primary focus 
was set on the post-intervention assessment. Loss to follow-up therefore mainly limits the 
interpretability of the results regarding our secondary outcomes and the frequency of tobacco 
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and cannabis use. A further limitation is that we did not include an assessment-only control 
group and could therefore not control for baseline assessment effects. This again represents a 
reason that our primary focus was on the post-intervention assessment. In addition, the 
interventions between baseline and the post-intervention assessment were very brief. 
Therefore, individuals of an assessment-only control group would have had to be reassessed 
after less than 30 minutes. Finally, the NF and MI interventions differed in length. While the 
intervention sessions for MI and PE participants both lasted nearly 30 minutes, the duration of 
an NF intervention session was approximately 11 minutes shorter. This difference was also 
reflected in the higher participation rate among NF participants in the post-intervention 
session. The possibility that we would have achieved significant differences between these 
two interventions if they would have been equally long can therefore not be excluded. 
Comparison with Prior Findings 
The comparability to prior studies is limited because no web-based interventions that target 
the co-use of tobacco and cannabis have been published. Additionally, web-based MI 
interventions that are delivered fully automated and do not use chat-based MI- counselling are 
rare. However, the significant time effect in our study and the absence of differential 
intervention effects on readiness to quit are in line with the findings of a study that compared 
a single-session of MI-based chat-intervention with a chat in which participants received 
technical information about the baseline self-test (Jonas et al., 2012). That study included 
problematic alcohol and cannabis users but targeted only the particular problem behaviour. 
The interventions were comparable to the MI and PE interventions of the current study with 
regard to their length but differed from the current interventions because they were not 
delivered in an automated fashion.  
Moreover, we speculate that providing knowledge was a relatively effective measure in 
our study because co-smokers’ baseline knowledge about the relationship between tobacco 
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and cannabis use seems to be generally modest (Becker et al., 2013). In addition, the psycho-
educational intervention was the only intervention that provided information on the risk of 
physical harm from cannabis use. In one previous study, awareness of this risk was a 
significant predictor of readiness to simultaneously quit (Becker et al., 2013).  
There are several possible explanations for the lack of time effects on the frequency of 
tobacco and cannabis use. First, the interventions were conceptualised as motivational 
enhancement interventions and targeted co-smokers who were in lower stages in the process 
of behaviour change. The interventions therefore mainly contained motivational contents and 
only very few elements that are commonly applied to support the cessation or reduction of 
tobacco or cannabis use, such as the development of personal strategies or skills training. It 
has been previously shown that the effectiveness of internet interventions in creating 
behaviour change is associated with the incorporation of behaviour change techniques (Webb, 
Joseph, Yardley, & Michie, 2010). In addition, the studied interventions were very brief 
compared to web-based treatment interventions, which revealed significant effects on either 
tobacco use (Haug et al., 2011; Woodruff et al., 2007) or cannabis use (Rooke, Copeland, 
Norberg, Hine, & McCambridge, 2013; Tossmann, Jonas, Tensil, Lang, & Strüber, 2011). 
This explanation is supported by the fact that other studies that analysed web-based 
interventions of a comparable length also revealed no effect on cannabis use (Jonas et al., 
2012; C. M. Lee, Neighbors, Kilmer, & Larimer, 2010). It should also be considered that the 
current interventions targeted two behaviours simultaneously, which may require especially 
intensive interventions. Finally, the high attrition rate limits the interpretability of our findings 
concerning behaviour change. This limitation is also illustrated by the different findings from 
the intent-to-treat and the complete case analysis. 
Moreover, the appropriateness of fully automated MI is questionable because central 
components of the MI approach, such as therapeutic rapport, cannot be realised in an online 
setting. The efficacy of fully automated MI might be particularly limited when two 
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behaviours are targeted simultaneously, as this presumably provokes much ambivalence that 
cannot be counterbalanced by a therapist. However, in brief face-to-face interventions for 
universal drug prevention and early intervention, MI was also not more effective than advice 
(McCambridge et al., 2011, 2008). Compared to our study, however, significant changes over 
time in tobacco, cannabis, and alcohol use were achieved in both intervention groups. 
Furthermore, a web-based intervention to promote smoking cessation using seven 45-minute 
sessions with MI-based video-chat in a virtual reality world revealed both significant time and 
intervention effects but used an assessment-only control condition (Woodruff et al., 2007).  
Conclusions 
The findings of this study suggest that brief, fully automated web-based interventions have a 
short-term but perhaps no longer-term effect on co-smokers’ readiness to simultaneously quit 
tobacco and cannabis use. There were no differential intervention effects, indicating that 
psychoeducation is no less effective than are more individualised, interactive interventions 
when the co-use of tobacco and cannabis is targeted. Moreover, neither time nor intervention 
effects on substance use behaviour were found. For dual-health behaviour change, more 
intensive interventions regarding the length and the mode of administration (fully automated 
vs. face-to-face, text-chat or video-chat) may be needed. Future studies could examine more 
comprehensive web-based treatment interventions for co-smokers and examine the efficacy of 
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